Industries > Pharma > Cell-Based Assays Market Report to 2030
Cell-Based Assays Market Report to 2030
Forecasts by Product (Instruments (Microplates, Microplate Reader, Liquid Handling System), Consumables (Reagents, Assay Kits, Cell Lines, Probes & Labels), Software, Services), by Application (Drug Discovery, Basic Research, ADME Studies, Predictive Technology), by Technology (Automated Liquid Handling, Flow Cytometry, Label-Free Detection, High-Throughput Screening), by End-User (Pharma & Biotech Companies, Academic Institutes, CROs) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Cell-Based Assays Companies AND COVID-19 Recovery Scenarios
PUBLISHED: 04 March 2021
PAGES: 454
PRODUCT CODE: PHA1078
SUBMARKET:
Drug Discovery Development & Production
The cell-based assay market is estimated to grow at a CAGR of xx% over the forecast period. The rising preference for cell-based assays in drug discovery, increasing funding for cell-based research, and growth in the number of drug discovery activities are the key factors supporting the growth of the market.
Evolving economies, growing pandemic risk and communicable diseases and application of cell-based assay in oncology research area is assured to provide profitable growth opportunities to the players in this market. For instance, phenotypic screening approaches are again rising in popularity in the drug discovery business, there is a need for robust and efficient assays that enable the study of the nervous system. Phenotypic assays can be highly predictive for infectious and metabolic diseases, however, for more complex disease areas such as the nervous system and cancer, more effort needs to be placed in designing sufficient and accurate models and assays. Cell-based assays are now emerging, such as for pain sensitisation and also in the screening of clinical compounds to treat Alzheimer’s disease. It is hoped that the further development of these cell-based assays will open the door for phenotypic screening approaches in nervous system and pain drug discovery thus, bolstering the growth of the market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
The report provides a profound understanding into the global cell-based assay market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the cell-based assay industry in any manner.
As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
To access the data contained in this document please email contactus@visiongain.com
In this brand-new 454-page report you will receive 283 charts– all unavailable elsewhere. The 454-page Visiongain report provides clear detailed insight into the cell-based assay market. Discover the key trends and development in the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global cell-based assay market forecasts from 2020-2030
• This report also breaks down the revenue forecast to 2030 for the global cell-based assay market by product, technology, application and end-user:
By Product
• Consumables
• Instruments
• Software & Services
By Technology
• Automated Handling
• Flow Cytometry
• Label-Free Detection
• High-Throughput Screening
By Application
• Drug Discovery
• Basic Research
• ADME Studies
• Predictive Technology
By End-User
• Pharma & Biotech Companies
• Academic Institutes
• CROs
This report discusses the market trends and developments of each submarket.
Need industry data? Please contact us today.
Our study discusses the selected leading companies that are the major players in the cell-based assay market:
• DiscoverX Corporation (Eurofins DiscoverX)
• Thermo Fisher Scientific
• Cell Assay Innovations, Inc.
• InSphero AG
• QGel SA.
• Becton, Dickinson and Company
• Promega Corporation
• BioVision, Inc.
• Marin Biologic Laboratories
• Molecular Devices, LLC. (Danaher Corporation)
• Porsolt
• CYTOO SA
• Pharmaceutical Product Development, LLC.
• ProQinase GmbH
• Charles River Laboratories International, Inc.
• BioAgilytix Labs
• SGS Group
• Perkin Elmer Inc.
• General Electric Company (GE Healthcare)
• F. Hoffmann-La Roche AG
• Merck KGaA
• Corning Inc.
• Bio-Rad Laboratories
Visiongain’s study is intended for anyone requiring commercial analyses for the global cell-based assay market. You find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Cell-Based Assays Market Report to 2030: Forecasts by Product (Instruments (Microplates, Microplate Reader, Liquid Handling System), Consumables (Reagents, Assay Kits, Cell Lines, Probes & Labels), Software, Services), by Application (Drug Discovery, Basic Research, ADME Studies, Predictive Technology), by Technology (Automated Liquid Handling, Flow Cytometry, Label-Free Detection, High-Throughput Screening), by End-User (Pharma & Biotech Companies, Academic Institutes, CROs) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Cell-Based Assays Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Cell-Based Assays Market Segmentation
1.2 Why You Should Read This Report
1.3 What This Report Delivers
1.4 Key Questions Answered By This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.7 COVID-19 Impact: Recovery Scenarios
1.8 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQs)
1.10 Associated Reports
1.11 About Visiongain
2. Introduction to Cell-Based Assays
2.1 Cell-Based Assays Overview
2.2 Cost of New Drug Discovery and Development Reaches $1.5bn – Companies Constantly Looking for Increased Efficiencies
2.3 Drug Discovery Approaches – Target-Based and Phenotype-Based Discovery
2.4 Drug Screening Assays
2.5 Animal Models Present In Vivo Conditions: But Do Results Translate to Humans?
2.6 Biochemical Assays and their Advantages over Animal Models
2.7 Applications of Biochemical Assays
2.8 Lead Identification and Toxicity Testing
2.9 Cell-Based Assays and their Advantages
2.10 2D vs 3D Cell-Based Assays
2.11 Advanced Cell-Based Assays
2.12 The Different Assay Detection Methods and Technologies
2.13 Cells used in Cell-Based Assays
2.14 Immortalised Cell Lines – Convenient but not Truly Representative of Normal Human Cell Lines
2.15 Primary Cells: Closer to the In Vivo Environment
2.16 Stem Cells: Potential to Overcome Limitations of Primary cells and Immortalised Cell Lines
2.17 Uses for Cell-Based Assays in Drug Discovery and Development
2.18 High Throughput Screening: Greatly Increases Efficiency
3. Executive Summary
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Trends
4.5 SWOT Analysis of the Cell-Based Assays Market
4.6 STEP Analysis of the Cell-Based Assays Market
4.7 Porter’s Five Forces Analysis
5. COVID Impact: Cell-Based Assays Market 2020
6. Global Cell-Based Assays Market Forecast 2020-2030
6.1 Global Cell-based Assays Market Forecasts 2020-2030
6.2 Global Cell-based Assays Market: COVID-19 Recovery Revenue Forecasts (V, U, W, L) 2020-2030
7. Cell-Based Assays Market by Product: Forecasts 2020-2030
7.1 Global Instruments Market: Revenue Forecasts 2020-2030
7.1.1 Increasing Focus on Drug Discovery is Driving the Instruments Segment
7.2 Global Instruments Market: Recovery Revenue Forecasts (V, U, W, L)
7.2.1 Global Microplates Market: Revenue Forecast 2020-2030
7.2.2 Global Microplates Market: Recovery Revenue Forecasts (V, U, W, L)
7.2.3 Global Microplate Reader Market: Revenue Forecasts 2020-2030
7.2.4 Global Microplate Readers Market: Recovery Revenue Forecasts (V, U, W, L)
7.2.5 Global Liquid Handling System Market: Revenue Forecasts 2020-2030
7.2.6 Global Liquid Handling System Market: Recovery Revenue Forecasts (V, U, W, L)
7.3 Global Consumables Market: Revenue Forecasts 2020-2030
7.3.1 Surge of Investments in the Field of Pharmaceuticals and Drug Discovery
7.3.2 Global Consumables Market: Recovery Revenue Forecasts (V, U, W, L)
7.3.3 Global Reagents Market: Revenue Forecasts 2020-2030
7.3.3.1 .Global Reagents Market: Recovery Revenue Forecasts (V, U, W, L)
7.3.4 Global Assay Kits Market: Revenue Forecasts 2020-2030
7.3.4.1Global Assay Kits Market: Recovery Revenue Forecasts (V, U, W, L)
7.3.5 Global Cell Lines Market: Revenue Forecasts 2020-2030
7.3.6 Global Cell Lines Market: Recovery Revenue Forecasts (V, U, W, L)
7.3.7 Global Probes and Labels Market: Revenue Forecasts 2020-2030
7.3.8 Global Probes and Labels Market: Recovery Revenue Forecasts (V, U, W, L)
7.4 Global Software Market: Revenue Forecasts 2020-2030
7.4.1 Technological Advancement in the Software Segment boosting its Adoption
7.4.2 Global Software Market: Recovery Revenue Forecasts (V, U, W, L)
7.5 Global Services Market: Revenue Forecasts 2020-2030
7.5.1 Rising Outsourcing of Product R&D by Pharmaceutical & Biotechnology Companies
7.5.2 Global Services Market: Recovery Revenue Forecasts (V, U, W, L)
8. Cell-Based Assays Market by Technology: Forecasts 2020-2030
8.1 Global High Throughput Screening Market: Revenue Forecasts 2020-2030
8.1.1 HTS is Vital in drug R&D
8.1.2 Global High Throughput Screening Market: Recovery Revenue Forecasts (V, U, W, L)
8.2 Global Automated Liquid Handling Market: Revenue Forecasts 2020-2030
8.2.1 Rising Technological Advances in the Area of Automated Liquid Handing
8.2.2 Global Automated Liquid Handling Market: Recovery Revenue Forecasts (V, U, W, L)
8.3 Global Flow Cytometry Market: Revenue Forecasts 2020-2030
8.3.1 One of the Widely Used Technology in the Pharmaceutical & Biotechnology Industry
8.3.2 Global Flow Cytometry Market: Recovery Revenue Forecasts (V, U, W, L)
8.4 Global Label-Free Detection Market: Revenue Forecasts 2020-2030
8.4.1 Label-Free Detection Technology is a Promising Analytical Tool in Cell-Based Assays
8.4.2 Global Label-Free Detection Market: Recovery Revenue Forecasts (V, U, W, L)
9. Cell-Based Assays Market by Application: Forecasts 2020-2030
9.1 Global Drug Discovery Market: Revenue Forecasts 2020-2030
9.1.1 Recent Developments in the Cell-Based Assays for Drug Discovery is Propelling the Segment Growth
9.1.2 Global Drug Discovery Market: Recovery Revenue Forecasts (V, U, W, L)
9.2 Global Basic Research Market: Revenue Forecasts 2020-2030
9.2.1 Segment Growth
9.2.2 Global Basic Research Market: Recovery Revenue Forecasts (V, U, W, L)
9.3 Global Predictive Technology Market: Revenue Forecasts 2020-2030
9.3.1 Growing Demand for the Advanced Technologies for Disease Diagnosis and Drug Development
9.3.2 Global Predictive Technology Market: Recovery Revenue Forecasts (V, U, W, L)
9.4 Global ADME Market: Revenue Forecasts 2020-2030
9.4.1 Introduction of Technologically Advanced Computer-Based Testing Models
9.4.2 Global ADME Toxicity Testing Market: Recovery Revenue Forecasts (V, U, W, L)
10. Cell-Based Assays Market by End-User: Forecasts 2020-2030
10.1 Global Pharma & Biotech Companies Market: Revenue Forecasts 2020-2030
10.1.1 Largest Revenue Grossing Segment
10.1.2 Global Pharma & Biotech Companies Market: Recovery Revenue Forecasts (V, U, W, L)
10.2 Global Academic Institutions Market: Revenue Forecasts 2020-2030
10.2.1 One of The Fast Growing Segment
10.2.2 Global Academic Institutions Market: Recovery Revenue Forecasts (V, U, W, L)
10.3 Global Contract Research Organizations (CROs) Market: Revenue Forecasts 2020-2030
10.3.1 Pharmaceutical Outsourcing has witnessed a Significant Transformation over The Past Few Decades
10.3.2 Global Contract Research Organizations (CROs) Market: Recovery Revenue Forecasts (V, U, W, L)
11. Regional and Leading National Cell-Based Assays Market Forecasts 2020-2030
11.1 Regional Breakdown of the Global Cell-Based Assays Market, 2020-2030
11.2 Global Cell-Based Assays Market: Regional Forecast 2020-2030
11.3 North America Cell-Based Assays Revenue Forecast 2020-2030
11.3.1 Largest Revenue-Generating Regional Market
11.3.2 North America Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.3.3 The US Cell-Based Assays Revenue Forecast 2020-2030
11.3.4 U.S Dominated the North America Market
11.3.5 Stringent Demands for Safety Data from the FDA
11.3.6 US Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.3.7 Canada Cell-Based Assays Revenue Forecast 2020-2030
11.3.8 Canada is one of the leading locations for clinical trials for the pharma industry
11.3.9 Canada Pharmaceutical Market has an opportunity to flourish
11.3.10 Canada Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4 European Union (EU) Cell-Based Assays Market 2020-2030
11.4.1 Increasing Research Activities In European Region
11.4.2 Growing User Demand for Advanced Products In European Region
11.4.3 European Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.4 Europe National Market Share Breakdown, 2020, 2025 and 2030
11.4.5 European Market: Main National Market Forecasts, 2020-2030
11.4.6 German Cell-Based Assay Revenue Forecast, 2020-2030
11.4.7 Pharmaceutical companies in Germany are aggressively involved in drug development
11.4.8 German market will remain the largest in Europe
11.4.9 Germany Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.10 French Cell-Based Assays Revenue Forecast, 2020-2030
11.4.11 Research Institutes in France Focuses in collaboration with foreign institutions
11.4.12 Growing Adoption of Advanced technology
11.4.13 French Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.14 UK Cell-Based Assays Revenue Forecast, 2020-2030
11.4.15 Collaborations among the biotech companies in the UK
11.4.16 The UK is the third biggest cell-based assays
11.4.17 UK Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.18 Spanish Cell-Based Assays Revenue Forecast, 2020-2030
11.4.19 Spain is emerging as an important biotechnology hub in Europe
11.4.20 Rising Biotechnology Research Investment in Spain
11.4.21 Spanish Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.22 Italian Cell-Based Assays Revenue Forecast, 2020-2030
11.4.23 Partner research organizations and biotech start-ups involved in developing cell-based assay solutions and services
11.4.24 High demand for advanced medicines
11.4.25 Italian Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.26 Russia Cell-Based Assays Revenue Forecast, 2020-2030
11.4.27 Improving regulatory policies to develop the domestic pharmaceutical industry and Collaboration among Biotechnology Companies and Research Institutes
11.4.28 Russian Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.29 Sweden Cell-Based Assays Revenue Forecast, 2020-2030
11.4.30 Sweden’s pharmaceutical sector is becoming increasingly important to the country’s economy
11.4.31 Sweden is expected to acquire the seventh largest share of the European cell-based assays market
11.4.32 Sweden Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.33 Denmark Cell-Based Assays Revenue Forecast, 2020-2030
11.4.34 Denmark is an increasingly attractive location for businesses that depend on clinical trials
11.4.35 Many well-established Contract Research Organizations with expertise in setting up
11.4.36 Denmark Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.37 Finland Cell-Based Assays Revenue Forecast, 2020-2030
11.4.38 Finland has seen a dynamic bioscience industry spring up and it is one of the fast-growing markets
11.4.39 Finland Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.40 Norway Cell-Based Assays Revenue Forecast, 2020-2030
11.4.41 High Investment in the Healthcare Sector
11.4.42 The growing pharmaceutical industry in Norway
11.4.43 Norway Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.44 Rest of Europe Cell-Based Assays Revenue Forecast, 2020-2030
11.4.45 Rest of Europe Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.5 Asia-Pacific Cell-Based Assays Market 2020-2030
11.5.1 Asia Pacific Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.5.2 APAC Countries National Breakdown, 2020, 2025 and 2030
11.5.3 APAC Market National Forecasts, 2020-2030
11.5.4 Japanese Cell-Based Assays Revenue Forecast, 2020-2030
11.5.5 Japanese biotechnology and pharmaceutical companies focus on strategic collaborations
11.5.6 Japan has the world’s second-largest pharmaceutical market
11.5.7 Japanese Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.5.8 Chinese Cell-Based Assay Revenue Forecast, 2020-2030
11.5.9 One of the most important markets in the world
11.5.10 China is the second-largest cell-based assay market amongst the APAC Region
11.5.11 Chinese Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.5.12 Indian Cell-Based Assays Revenue Forecast, 2020-2030
11.5.13 India has been gaining increasing significance in the global drug R&D
11.5.14 India is an attractive market for pharmaceutical companies
11.5.15 Indian Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.5.16 Rest of APAC Cell-Based Assays Revenue Forecast, 2020-2030
11.5.17 Rest of APAC Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.6 LATAM Cell-Based Assays Market 2020-2030
11.6.1 Latin America Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.6.2 LATAM Countries National Breakdown, 2020, 2025 and 2030
11.6.3 LATAM Countries National Forecasts, 2020-2030
11.6.4 Brazilian Cell-Based Assays Revenue Forecast, 2020-2030
11.6.5 Investment by pharmaceutical & biotechnology companies in this region
11.6.6 Largest Market in Latin America
11.6.7 Brazilian Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.6.8 Mexico Cell-Based Assays Revenue Forecast, 2020-2030
11.6.9 Significant local production of active ingredients and finished products
11.6.10 Mexico has signed many Free Trade Agreements
11.6.11 Mexico Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.6.12 Rest of LATAM Cell-Based Assays Revenue Forecast, 2020-2030
11.6.13 Rest of LATAM Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.7 Middle-East & Africa (MEA) Cell-Based Assays Market 2020-2030
11.7.1 MEA Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
12. Leading Companies in the Cell-Based Assays Market, 2020-2030
12.1 DiscoverX Corporation (Eurofins DiscoverX)
12.2 Thermo Fisher Scientific
12.3 Cell Assay Innovations, Inc.
12.4 InSphero AG
12.5 QGel SA.
12.6 Becton, Dickinson and Company
12.7 Promega Corporation
12.8 BioVision, Inc.
12.9 Marin Biologic Laboratories
12.10 Molecular Devices, LLC. (Danaher Corporation)
12.11 Porsolt
12.12 CYTOO SA
12.13 Pharmaceutical Product Development, LLC.
12.14 ProQinase GmbH
12.15 Charles River Laboratories International, Inc.
12.16 BioAgilytix Labs
12.17 SGS Group
12.18 Perkin Elmer Inc.
12.19 General Electric Company (GE Healthcare)
12.20 F. Hoffmann-La Roche AG
12.21 Merck KGaA
12.22 Corning Inc.
12.23 Bio-Rad Laboratories
13. Cell-Based Assays Technology, Trends and Future Outlook
13.1 Stem Cells: Vast Potential
13.2 The Benefits of Using Stem Cells in Cell-Based Assays
13.3 iPSCs: An Uncontroversial and Abundant Source
13.4 Companies Providing Stem Cell-Based Assays
13.5 Toxicity Testing: Important Field for Cell-Based Assays
13.6 3D Systems: The Advantages of Next Generation of Cell Systems
13.7 Complexity of 3D Systems is a Challenge but many are reaching the Market
13.8 Organoids – The Future of Drug Development
13.9 Bio-Printing for Drug Development: Using 3D Printing Technology
13.10 Increasing Outsourcing of Cell-Based Assays
13.11 Label-Free Technology
13.12 GPCRs: A Common Drug and Drug Discovery Target
13.13 Allosteric GPCRs
13.14 Increasing Miniaturisation and Automation
13.15 Advantages of Miniaturisation
13.16 Advantages of Automation
13.17 Microfluids are Set to be a Trend
13.18 Multiplexing: Improves Efficiency of Cell-Based Assays
13.19 High Content Screening: A Well-Established Tool
13.20 Cell-Based Assays for the Development of Biologics
14. Conclusions
14.1 Growth Has Been Driven by Advantages of Cell-Based Assays
14.2 Current Status of the Market and its Growth Drivers
14.3 The Most Dominant National Markets and Emerging Countries
14.4 Future Trends and Technology
List of Tables
Table 1 Main Parameters Required in Drug Discovery and Development
Table 2 Selected Label-Free Detection Technologies Used for Cell-Based Assays
Table 3 Cell-Based Assays for HTS in Drug Screening
Table 4 Global Cell-based Assays Market, 2020-2030 (US$ million, CAGR %)
Table 5 Global Cell-based Assays Market Forecasts, 2020-2030 (US$ million, AGR %, CAGR %)
Table 6 “V” Shaped Recovery: Global Cell-based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 7 “U” Shaped Recovery: Global Cell-based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 8 “W” Shaped Recovery: Global Cell-based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 9 “L” Shaped Recovery: Global Cell-based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 10 Global Cell-based Assays Market Forecast by Product, 2020-2030 (US$ million, AGR %, CAGR %)
Table 11 Global Instruments Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 12 “V” Shaped Recovery: Global Instruments Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 13 “U” Shaped Recovery: Global Instruments Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 14 “W” Shaped Recovery: Global Instruments Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 18 “W” Shaped Recovery: Global Instruments Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Table 15 “L” Shaped Recovery: Global Instruments Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 16 Global Microplates Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 17 “V” Shaped Recovery: Global Microplates Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 18 “U” Shaped Recovery: Global Microplates Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 19 “W” Shaped Recovery: Global Microplates Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 20 “L” Shaped Recovery: Global Microplates Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 21 Global Microplate Readers Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 22 “V” Shaped Recovery: Global Microplate Readers Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 23 “U” Shaped Recovery: Global Microplate Readers Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 24 “W” Shaped Recovery: Global Microplate Readers Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 25 “L” Shaped Recovery: Global Microplate Readers Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 26 Global Liquid Handling System Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 27 “V” Shaped Recovery: Global Liquid Handling System Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 28 “U” Shaped Recovery: Global Liquid Handling System Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 29 “W” Shaped Recovery: Global Liquid Handling System Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 30 “L” Shaped Recovery: Global Liquid Handling System Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 31 Global Consumables Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 32 “V” Shaped Recovery: Global Consumables Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 33 “U” Shaped Recovery: Global Consumables Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 34 “W” Shaped Recovery: Global Consumables Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 35 “L” Shaped Recovery: Global Consumables Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 36 Global Reagents Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 37 “V” Shaped Recovery: Global Reagents Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 38 “U” Shaped Recovery: Global Reagents Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 40 “L” Shaped Recovery: Global Reagents Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 44 “L” Shaped Recovery: Global Reagents Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Table 41 Global Assay Kits Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 42 “V” Shaped Recovery: Global Assay Kits Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 43 “U” Shaped Recovery: Global Assay Kits Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 44 “W” Shaped Recovery: Global Assay Kits Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 45 “L” Shaped Recovery: Global Assay Kits Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 46 Global Cell Lines Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 47 “V” Shaped Recovery: Global Cell Lines Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 48 “U” Shaped Recovery: Global Cell Lines Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 49 “W” Shaped Recovery: Global Cell Lines Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 50 “L” Shaped Recovery: Global Cell Lines Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 51 Global Probes and Labels Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 52 “V” Shaped Recovery: Global Probes and Labels Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 53 “U” Shaped Recovery: Global Probes and Labels Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 54 “W” Shaped Recovery: Global Probes and Labels Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 55 “L” Shaped Recovery: Global Probes and Labels Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 56 Global Software Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 57 “V” Shaped Recovery: Global Software Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 58 “U” Shaped Recovery: Global Software Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 59 “W” Shaped Recovery: Global Software Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 60 “L” Shaped Recovery: Global Software Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 61 Global Services Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 62 “V” Shaped Recovery: Global Services Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 63 “U” Shaped Recovery: Global Services Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 64 “W” Shaped Recovery: Global Services Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 65 “L” Shaped Recovery: Global Services Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 66 Global Cell-based Assays Market Forecast by Technology, 2020-2030 (US$ million, AGR %, CAGR %)
Table 67 Global High Throughput Screening Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 68 “V” Shaped Recovery: Global High Throughput Screening Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 69 “U” Shaped Recovery: Global High Throughput Screening Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 70 “W” Shaped Recovery: Global High Throughput Screening Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 71 “L” Shaped Recovery: Global High Throughput Screening Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 72 Global Automated Liquid Handling Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 73 “V” Shaped Recovery: Global Automated Liquid Handling Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 74 “U” Shaped Recovery: Global Automated Liquid Handling Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 75 “W” Shaped Recovery: Global Automated Liquid Handling Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 76 “L” Shaped Recovery: Global Automated Liquid Handling Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 77 Global Flow Cytometry Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 78 “V” Shaped Recovery: Global Flow Cytometry Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 79 “U” Shaped Recovery: Global Flow Cytometry Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 80 “W” Shaped Recovery: Global Flow Cytometry Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 81 “L” Shaped Recovery: Global Flow Cytometry Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 82 Global Label-Free Detection Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 83 “V” Shaped Recovery: Global Label-Free Detection Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 84 “U” Shaped Recovery: Global Label-Free Detection Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 85 “W” Shaped Recovery: Global Label-Free Detection Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 86 “L” Shaped Recovery: Global Label-Free Detection Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 87 Global Cell-based Assays Market Forecast by Application, 2020-2030 (US$ million, AGR %, CAGR %)
Table 88 Global Drug Discovery Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 89 “V” Shaped Recovery: Global Drug Discovery Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 90 “U” Shaped Recovery: Global Drug Discovery Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 94 “U” Shaped Recovery: Global Drug Discovery Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 95 “W” Shaped Recovery: Global Drug Discovery Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 97 “L” Shaped Recovery: Global Drug Discovery Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 99 Global Basic Research Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 101 “V” Shaped Recovery: Global Basic Research Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 103 “U” Shaped Recovery: Global Basic Research Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 105 “W” Shaped Recovery: Global Basic Research Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 107 “L” Shaped Recovery: Global Basic Research Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 109 Global Predictive Technology Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 111 “V” Shaped Recovery: Global Predictive Technology Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 113 “U” Shaped Recovery: Global Predictive Technology Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 115 “W” Shaped Recovery: Global Predictive Technology Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 118 Global ADME Toxicity Testing Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 121 “U” Shaped Recovery: Global ADME Toxicity Testing Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 95 Global Cell-based Assays Market Forecast by End-User, 2020-2030 (US$ million, AGR %, CAGR %)
Table 96 Global Pharma & Biotech Companies Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 97 “V” Shaped Recovery: Global Pharma & Biotech Companies Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 98 “U” Shaped Recovery: Global Pharma & Biotech Companies Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 99 “W” Shaped Recovery: Global Pharma & Biotech Companies Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 100 “L” Shaped Recovery: Global Pharma & Biotech Companies Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 101 Global Academic Institutions Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 102 “V” Shaped Recovery: Global Academic Institutions Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 103 “U” Shaped Recovery: Global Academic Institutions Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 104 “W” Shaped Recovery: Global Academic Institutions Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 105 “L” Shaped Recovery: Global Academic Institutions Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 106 Global Contract Research Organizations (CROs) Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 107 “V” Shaped Recovery: Global Contract Research Organizations (CROs) Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 108 “U” Shaped Recovery: Global Contract Research Organizations (CROs) Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 109 “W” Shaped Recovery: Global Contract Research Organizations (CROs) Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 110 “L” Shaped Recovery: Global Contract Research Organizations (CROs) Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 111 Global Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2020, 2025, & 2030
Table 112 Global Cell-based Assays Market Forecast by Region, 2020-2030 (US$ million, AGR %, CAGR %)
Table 113 North America Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 115 “U” Shaped Recovery: North America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 116 “W” Shaped Recovery: North America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 117 “L” Shaped Recovery: North America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 118 US Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 119 “V” Shaped Recovery: US Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 120 “U” Shaped Recovery: US Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 121 “W” Shaped Recovery: US Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 122 “L” Shaped Recovery: US Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 123 Canada Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 125 “U” Shaped Recovery: Canada Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 126 “W” Shaped Recovery: Canada Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 127 “L” Shaped Recovery: Canada Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 128 European Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 129 “V” Shaped Recovery: European Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 130 “U” Shaped Recovery: European Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 131 “W” Shaped Recovery: European Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 132 “L” Shaped Recovery: European Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 134 Europe Cell-based Assays Market Forecast by Region, 2020-2030 (US$ million, AGR %, CAGR %)
Table 135 Germany Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 136 “V” Shaped Recovery: Germany Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 137 “U” Shaped Recovery: Germany Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 138 “W” Shaped Recovery: Germany Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 139 “L” Shaped Recovery: Germany Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 140 French Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 141 “V” Shaped Recovery: French Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 142 “U” Shaped Recovery: French Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 143 “W” Shaped Recovery: French Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 144 “L” Shaped Recovery: French Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 167 “U” Shaped Recovery: Sweden Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 168 “W” Shaped Recovery: Sweden Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 169 “L” Shaped Recovery: Sweden Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 170 Denmark Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 171 “V” Shaped Recovery: Denmark Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 172 “U” Shaped Recovery: Denmark Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 173 “W” Shaped Recovery: Denmark Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 174 “L” Shaped Recovery: Denmark Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 175 “L” Shaped Recovery: Denmark Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Table 176 Finland Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 177 “V” Shaped Recovery: Finland Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 178 “U” Shaped Recovery: Finland Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 179 “W” Shaped Recovery: Finland Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 180 “L” Shaped Recovery: Finland Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 181 Norway Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 182 “V” Shaped Recovery: Norway Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 183 “U” Shaped Recovery: Norway Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 184 “W” Shaped Recovery: Norway Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 185 “L” Shaped Recovery: Norway Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 186 “L” Shaped Recovery: Norway Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Table 187 Rest of Europe Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 188 Rest of Europe Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Table 189 “V” Shaped Recovery: Rest of Europe Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 190 “U” Shaped Recovery: Rest of Europe Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 191 “W” Shaped Recovery: Rest of Europe Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 192 “L” Shaped Recovery: Rest of Europe Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 193 Asia Pacific Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 194 “V” Shaped Recovery: Asia Pacific Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 195 “U” Shaped Recovery: Asia Pacific Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 196 “W” Shaped Recovery: Asia Pacific Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 197 “L” Shaped Recovery: Asia Pacific Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 198 Asia Pacific Cell-based Assays Market Forecast by Region, 2020-2030 (US$ million, AGR %, CAGR %)
Table 199 Japanese Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 200 “V” Shaped Recovery: Japanese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 201 “U” Shaped Recovery: Japanese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 202 “W” Shaped Recovery: Japanese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 203 “L” Shaped Recovery: Japanese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 204 Chinese Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 205 “V” Shaped Recovery: Chinese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 206 “U” Shaped Recovery: Chinese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 207 “W” Shaped Recovery: Chinese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 208 “L” Shaped Recovery: Chinese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 209 Indian Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 210 “V” Shaped Recovery: Indian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 211 “U” Shaped Recovery: Indian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 212 “W” Shaped Recovery: Indian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 213 “L” Shaped Recovery: Indian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 214 Rest of APAC Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 215 “V” Shaped Recovery: Rest of APAC Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 216 “U” Shaped Recovery: Rest of APAC Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 217 “W” Shaped Recovery: Rest of APAC Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 218 “L” Shaped Recovery: Rest of APAC Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 219 Latin America Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 220 “V” Shaped Recovery: Latin America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 221 “U” Shaped Recovery: Latin America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 222 “W” Shaped Recovery: Latin America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 223 “L” Shaped Recovery: Latin America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 225 Latin America Cell-based Assays Market Forecast by Region, 2020-2030 (US$ million, AGR %, CAGR %)
Table 226 Brazilian Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 227 “V” Shaped Recovery: Brazilian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 228 “U” Shaped Recovery: Brazilian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 229 “W” Shaped Recovery: Brazilian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 230 “L” Shaped Recovery: Brazilian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 231 Mexico Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 232 “V” Shaped Recovery: Mexico Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 233 “U” Shaped Recovery: Mexico Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 234 “W” Shaped Recovery: Mexico Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 235 “L” Shaped Recovery: Mexico Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 236 Rest of LATAM Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 237 “V” Shaped Recovery: Rest of LATAM Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 238 “U” Shaped Recovery: Rest of LATAM Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 239 “W” Shaped Recovery: Rest of LATAM Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 240 “L” Shaped Recovery: Rest of LATAM Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 241 MEA Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 242 “V” Shaped Recovery: MEA Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 244 “W” Shaped Recovery: MEA Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 245 “L” Shaped Recovery: MEA Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 246 Eurofins DiscoverX: Company Profile
Table 247 DiscoverX: Cell-based Assay Product Portfolio
Table 248 Thermo Fisher Scientific, Inc.: Company Profile
Table 249 Thermo Fisher Scientific, Inc.: Cell-based Assay Product Portfolio
Table 250 Thermo Fisher Scientific: Net Revenues, 2016-2019 ($Million)
Table 251 Cell Assay Innovations, Inc.: Company Profile
Table 253 InSphero AG: Company Profile
Table 254 InSphero AG: Cell-based Assay Product Portfolio
Table 255 QGel SA.: Company Profile
Table 256 QGel SA.: Cell-based Assay Product Portfolio
Table 257 Becton, Dickinson and Company: Company Profile
Table 258 Becton, Dickinson and Company: Cell-based Assay Product Portfolio
Table 261 BioVision, Inc.: Company Profile
Table 262 BioVision, Inc.: Cell-based Assay Product Portfolio
Table 263 Marin Biologic Laboratories: Company Profile
Table 264 Marin Biologic Laboratories: Cell-based Assay Product Portfolio
Table 265 Molecular Devices, LLC.: Company Profile
Table 266 Molecular Devices, LLC.: Cell-based Assay Product Portfolio
Table 267 Porsolt: Company Profile
Table 268 Porsolt: Cell-based Assay Product Portfolio
Table 269 CYTOO SA: Company Profile
Table 270 CYTOO SA: Cell-based Assay Product Portfolio
Table 271 Pharmaceutical Product Development, LLC.: Company Profile
Table 272 Pharmaceutical Product Development, LLC.: Cell-based Assay Product Portfolio
Table 273 ProQinase GmbH: Company Profile
Table 274 ProQinase GmbH: Cell-based Assay Product Portfolio
Table 275 Charles River Laboratories International, Inc.: Company Profile
Table 276 Charles River Laboratories International, Inc.: Cell-based Assay Product Portfolio
Table 277 BioAgilytix Labs: Company Profile
Table 278 BioAgilytix Labs: Cell-based Assay Product Portfolio
Table 279 SGS Group: Company Profile
Table 280 SGS Group: Cell-based Assay Product Portfolio
Table 281 Perkin Elmer Inc.: Company Profile
Table 282 Perkin Elmer Inc.: Cell-based Assay Product Portfolio
Table 283 General Electric: Company Profile
Table 285 F. Hoffmann-La Roche AG: Company Profile
Table 286 F. Hoffmann-La Roche AG: Cell-based Assay Product Portfolio
Table 287 Merck KGaA: Company Profile
Table 288 Merck KGaA: Cell-based Assay Product Portfolio
Table 289 Corning Inc.: Company Profile
Table 290 Corning Inc.: Cell-based Assay Product Portfolio
Table 291 Bio-Rad Laboratories, Inc.: Company Profile
Table 292 Bio-Rad Laboratories, Inc.: Cell-based Assay Product Portfolio
Table 294 Selected Companies Offering Label-Free Assay Systems
List of Figures
Figure 1 Global Cell-based Assays Market Segmentation
Figure 2 Stages of Pre-Clinical Drug Development
Figure 3 Global Cell-based Assays Market Overview,2020
Figure 4 Estimated number of new lung cancer cases worldwide, 2012-2030
Figure 5 Estimated number of new pancreatic cancer cases worldwide, 2012-2030
Figure 6 Strengths and Weaknesses of the Cell-Based Assay Market, 2020
Figure 7 PEST Analysis, 2020
Figure 8 Porter’s Five Forces Analysis,2020
Figure 9 Global Cell-based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR %)
Figure 10 “V” Shaped Recovery: Global Cell-based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR %)
Figure 11 “U” Shaped Recovery: Global Cell-based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR %)
Figure 12 “W” Shaped Recovery: Global Cell-based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR %)
Figure 13 “L” Shaped Recovery: Global Cell-based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR %)
Figure 14 Global Cell-based Assays Market Share Forecast by Product, 2020, 2025, 2030 (%)
Figure 15 Global Instruments Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 16 “V” Shaped Recovery: Global Instruments Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 17 “U” Shaped Recovery: Global Instruments Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 18 “W” Shaped Recovery: Global Instruments Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 19 “L” Shaped Recovery: Global Instruments Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 20 Global Microplates Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 21 “V” Shaped Recovery: Global Microplates Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 22 “U” Shaped Recovery: Global Microplates Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 23 “W” Shaped Recovery: Global Microplates Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 24 “L” Shaped Recovery: Global Microplates Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 25 Global Microplate Readers Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 26 “V” Shaped Recovery: Global Microplate Readers Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 27 “U” Shaped Recovery: Global Microplate Readers Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 28 “W” Shaped Recovery: Global Microplate Readers Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 29 “L” Shaped Recovery: Global Microplate Readers Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 30 Global Liquid Handling System Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 31 “V” Shaped Recovery: Global Liquid Handling System Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 32 “U” Shaped Recovery: Global Liquid Handling System Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 33 “W” Shaped Recovery: Global Liquid Handling System Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 34 “L” Shaped Recovery: Global Liquid Handling System Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 35 Global Consumables Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 36 “V” Shaped Recovery: Global Consumables Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 37 “U” Shaped Recovery: Global Consumables Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 38 “W” Shaped Recovery: Global Consumables Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 39 “L” Shaped Recovery: Global Consumables Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 40 Global Reagents Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 41 “V” Shaped Recovery: Global Reagents Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 42 “U” Shaped Recovery: Global Reagents Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 43 “W” Shaped Recovery: Global Reagents Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 44 “L” Shaped Recovery: Global Reagents Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 45 Global Assay Kits Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 46 “V” Shaped Recovery: Global Assay Kits Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 47 “U” Shaped Recovery: Global Assay Kits Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 48 “W” Shaped Recovery: Global Assay Kits Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 49 “L” Shaped Recovery: Global Assay Kits Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 50 Global Cell Lines Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 51 “V” Shaped Recovery: Global Cell Lines Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 52 “U” Shaped Recovery: Global Cell Lines Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 53 “W” Shaped Recovery: Global Cell Lines Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 54 “L” Shaped Recovery: Global Cell Lines Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 55 Global Probes and Labels Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 56 “V” Shaped Recovery: Global Probes and Labels Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 57 “U” Shaped Recovery: Global Probes and Labels Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 58 “W” Shaped Recovery: Global Probes and Labels Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 59 “L” Shaped Recovery: Global Probes and Labels Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 60 Global Softwares Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 61 “V” Shaped Recovery: Global Softwares Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 62 “U” Shaped Recovery: Global Softwares Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 63 “W” Shaped Recovery: Global Softwares Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 64 “L” Shaped Recovery: Global Softwares Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 65 Global Services Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 66 “V” Shaped Recovery: Global Services Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 67 “U” Shaped Recovery: Global Services Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 68 “W” Shaped Recovery: Global Services Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 69 “L” Shaped Recovery: Global Services Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 70 Global Cell-based Assays Market Share Forecast by Technology, 2020, 2025, 2030 (%)
Figure 71 Global High Throughput Screening Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 72 “V” Shaped Recovery: Global High Throughput Screening Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 73 “U” Shaped Recovery: Global High Throughput Screening Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 74 “W” Shaped Recovery: Global High Throughput Screening Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 75 “L” Shaped Recovery: Global High Throughput Screening Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 76 Global Automated Liquid Handling Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 77 “V” Shaped Recovery: Global Automated Liquid Handling Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 78 “U” Shaped Recovery: Global Automated Liquid Handling Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 79 “W” Shaped Recovery: Global Automated Liquid Handling Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 80 “L” Shaped Recovery: Global Automated Liquid Handling Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 81 Global Flow Cytometry Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 82 “V” Shaped Recovery: Global Flow Cytometry Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 83 “U” Shaped Recovery: Global Flow Cytometry Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 84 “W” Shaped Recovery: Global Flow Cytometry Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 85 “L” Shaped Recovery: Global Flow Cytometry Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 86 Global Label-Free Detection Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 87 “V” Shaped Recovery: Global Label-Free Detection Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 88 “U” Shaped Recovery: Global Label-Free Detection Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 89 “W” Shaped Recovery: Global Label-Free Detection Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 90 “L” Shaped Recovery: Global Label-Free Detection Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 91 Global Cell-based Assays Market Share Forecast by Application, 2020, 2025, 2030 (%)
Figure 92 Global Drug Discovery Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 93 “V” Shaped Recovery: Global Drug Discovery Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 94 “U” Shaped Recovery: Global Drug Discovery Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 95 “W” Shaped Recovery: Global Drug Discovery Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 96 “L” Shaped Recovery: Global Drug Discovery Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 97 Global Basic Research Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 98 “V” Shaped Recovery: Global Basic Research Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 99 “U” Shaped Recovery: Global Basic Research Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 100 “W” Shaped Recovery: Global Basic Research Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 101 “L” Shaped Recovery: Global Basic Research Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 102 Global Predictive Technology Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 103 “V” Shaped Recovery: Global Predictive Technology Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 104 “U” Shaped Recovery: Global Predictive Technology Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 105 “W” Shaped Recovery: Global Predictive Technology Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 106 “L” Shaped Recovery: Global Predictive Technology Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 107 Global ADME Toxicity Testing Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 108 “V” Shaped Recovery: Global ADME Toxicity Testing Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 109 “U” Shaped Recovery: Global ADME Toxicity Testing Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 110 “W” Shaped Recovery: Global ADME Toxicity Testing Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 111 “L” Shaped Recovery: Global ADME Toxicity Testing Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 112 Global Cell-based Assays Market Share Forecast by End-User, 2020, 2025, 2030 (%)
Figure 113 Global Pharma & Biotech Companies Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 114 “V” Shaped Recovery: Global Pharma & Biotech Companies Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 115 “U” Shaped Recovery: Global Pharma & Biotech Companies Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 116 “W” Shaped Recovery: Global Pharma & Biotech Companies Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 117 “L” Shaped Recovery: Global Pharma & Biotech Companies Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 118 Global Academic Institutions Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 119 “V” Shaped Recovery: Global Academic Institutions Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 120 “U” Shaped Recovery: Global Academic Institutions Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 121 “W” Shaped Recovery: Global Academic Institutions Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 122 “L” Shaped Recovery: Global Academic Institutions Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 123 Global Contract Research Organizations (CROs) Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 124 “V” Shaped Recovery: Global Contract Research Organizations (CROs) Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 125 “U” Shaped Recovery: Global Contract Research Organizations (CROs) Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 126 “W” Shaped Recovery: Global Contract Research Organizations (CROs) Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 127 “L” Shaped Recovery: Global Contract Research Organizations (CROs) Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 128 Global Cell-Based Assays Market Forecast by Region 2020, 2025, & 2030 (% Share)
Figure 129 North America Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 130 “V” Shaped Recovery: North America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 131 “U” Shaped Recovery: North America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 132 “W” Shaped Recovery: North America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 133 “L” Shaped Recovery: North America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 134 US Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 135 “V” Shaped Recovery: US Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 136 “U” Shaped Recovery: US Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 137 “W” Shaped Recovery: US Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 138 “L” Shaped Recovery: US Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 139 Canada Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 140 “V” Shaped Recovery: Canada Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 141 “U” Shaped Recovery: Canada Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 142 “W” Shaped Recovery: Canada Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 143 “L” Shaped Recovery: Canada Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 144 European Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 145 “V” Shaped Recovery: European Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 146 “U” Shaped Recovery: European Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 147 “W” Shaped Recovery: European Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 148 “L” Shaped Recovery: European Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 149 Germany Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 150 “V” Shaped Recovery: Germany Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 151 “U” Shaped Recovery: Germany Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 152 “W” Shaped Recovery: Germany Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 153 “L” Shaped Recovery: Germany Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 154 French Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 155 “V” Shaped Recovery: French Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 156 “U” Shaped Recovery: French Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 157 “W” Shaped Recovery: French Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 158 “L” Shaped Recovery: French Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 159 UK Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 160 “V” Shaped Recovery: UK Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 161 “U” Shaped Recovery: UK Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 162 “W” Shaped Recovery: UK Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 163 “L” Shaped Recovery: UK Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 164 Spanish Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 165 “V” Shaped Recovery: Spanish Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 166 “U” Shaped Recovery: Spanish Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 167 “W” Shaped Recovery: Spanish Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 168 “L” Shaped Recovery: Spanish Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 169 Italian Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 170 “V” Shaped Recovery: Italian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 171 “U” Shaped Recovery: Italian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 172 “W” Shaped Recovery: Italian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 173 “L” Shaped Recovery: Italian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 174 Russian Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 175 “V” Shaped Recovery: Russian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 176 “U” Shaped Recovery: Russian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 177 “W” Shaped Recovery: Russian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 178 “L” Shaped Recovery: Russian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 179 Sweden Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 180 “V” Shaped Recovery: Sweden Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 181 “U” Shaped Recovery: Sweden Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 182 “W” Shaped Recovery: Sweden Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 183 “L” Shaped Recovery: Sweden Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 184 Denmark Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 185 “V” Shaped Recovery: Denmark Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 186 “U” Shaped Recovery: Denmark Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 187 “W” Shaped Recovery: Denmark Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 188 “L” Shaped Recovery: Denmark Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 189 Finland Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 190 “V” Shaped Recovery: Finland Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 191 “U” Shaped Recovery: Finland Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 192 “W” Shaped Recovery: Finland Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 193 “L” Shaped Recovery: Finland Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 194 Norway Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 195 “V” Shaped Recovery: Norway Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 196 “U” Shaped Recovery: Norway Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 197 “W” Shaped Recovery: Norway Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 198 “L” Shaped Recovery: Norway Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 199 Rest of Europe Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 200 “V” Shaped Recovery: Rest of Europe Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 201 “U” Shaped Recovery: Rest of Europe Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 202 “W” Shaped Recovery: Rest of Europe Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 203 “L” Shaped Recovery: Rest of Europe Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 204 Asia Pacific Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 205 “V” Shaped Recovery: Asia Pacific Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 206 “U” Shaped Recovery: Asia Pacific Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 207 “W” Shaped Recovery: Asia Pacific Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 208 “L” Shaped Recovery: Asia Pacific Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 209 Asia Pacific Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2020, 2025, & 2030
Figure 210 Japanese Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 211 “V” Shaped Recovery: Japanese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 212 “U” Shaped Recovery: Japanese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 213 “W” Shaped Recovery: Japanese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 214 “L” Shaped Recovery: Japanese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 215 Chinese Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 216 “V” Shaped Recovery: Chinese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 217 “U” Shaped Recovery: Chinese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 218 “W” Shaped Recovery: Chinese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 219 “L” Shaped Recovery: Chinese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 220 Indian Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 221 “V” Shaped Recovery: Indian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 222 “U” Shaped Recovery: Indian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 223 “W” Shaped Recovery: Indian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 224 “L” Shaped Recovery: Indian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 225 Rest of APAC Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 226 “V” Shaped Recovery: Rest of APAC Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 227 “U” Shaped Recovery: Rest of APAC Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 228 “W” Shaped Recovery: Rest of APAC Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 229 “L” Shaped Recovery: Rest of APAC Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 230 Latin America Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 231 “V” Shaped Recovery: Latin America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 232 “U” Shaped Recovery: Latin America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 233 “W” Shaped Recovery: Latin America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 234 “L” Shaped Recovery: Latin America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 235 Brazilian Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 236 “V” Shaped Recovery: Brazilian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 237 “U” Shaped Recovery: Brazilian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 238 “W” Shaped Recovery: Brazilian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 239 “L” Shaped Recovery: Brazilian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 240 Mexico Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 241 “V” Shaped Recovery: Mexico Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 242 “U” Shaped Recovery: Mexico Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 243 “W” Shaped Recovery: Mexico Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 244 “L” Shaped Recovery: Mexico Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 245 Rest of LATAM Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 246 “V” Shaped Recovery: Rest of LATAM Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 247 “U” Shaped Recovery: Rest of LATAM Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 248 “W” Shaped Recovery: Rest of LATAM Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 249 “L” Shaped Recovery: Rest of LATAM Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 250 MEA Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 251 “V” Shaped Recovery: MEA Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 252 “U” Shaped Recovery: MEA Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 253 “W” Shaped Recovery: MEA Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 254 “L” Shaped Recovery: MEA Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 255 Thermo Fisher Scientific: Net Revenues, 2016-2019 ($Million)
Figure 256 Thermo Fisher Scientific: Net Revenue (%) by Segment, 2019
Figure 257 Thermo Fisher Scientific: Net Revenue (%) by Geography, 2019
Figure 258 BD: Net Revenues ($Million) & AGR (%), 2016-2019
Figure 259 BD: Net Revenue (%) by Segment, 2019
Figure 260 BD: Net Revenue (%) by Geography, 2019
Figure 261 Danaher Corporation: Net Revenues, 2016-2019 ($Million), AGR %
Figure 262 Danaher Corporation: Net Revenue (%) by Segment, 2019
Figure 263 Danaher Corporation: Net Revenue (%) by Geography, 2019
Figure 264 Charles River Laboratories: Net Revenues, 2016-2019 ($Million), AGR %
Figure 265 Charles River Laboratories: Net Revenue (%) by Segment, 2019
Figure 266 Charles River Laboratories: Net Revenue (%) by Geography, 2019
Figure 267 SGS Group: Net Revenues, 2016-2019 ($Million), AGR %
Figure 268 SGS Group: Net Revenue (%) by Segment, 2019
Figure 269 SGS Group: Net Revenue (%) by Geography, 2019
Figure 270 Perkin Elmer Inc.: Net Revenues, 2016-2019 ($Million), AGR %
Figure 271 Perkin Elmer: Segment Revenues, 2019 (%)
Figure 272 Perkin Elmer: Regional Revenues, 2019 (%)
Figure 273 GE Healhcare: Net Revenues, 2016-2019 ($Million), AGR %
Figure 274 F. Hoffmann-La Roche AG: Net Revenues, 2016-2019 ($Million), AGR %
Figure 275 F. Hoffmann-La Roche AG: Net Revenue (%) by Segment, 2019
Figure 276 F. Hoffmann-La Roche AG: Net Revenue (%) by Geography, 2019
Figure 277 Merck KGaA: Net Revenues, 2016-2019 ($Million), AGR %
Figure 278 Merck KGaA: Net Revenue (%) by Segment, 2019
Figure 279 Merck KGaA: Net Revenue (%) by Geography, 2019
Figure 280 Corning Inc.: Net Revenues, 2016-2019 ($Million), AGR %
Figure 281 Corning Inc.: Net Revenue (%) by Segment, 2019
Figure 282 Corning Inc.: Net Revenue (%) by Geography, 2019
Figure 283 Bio-Rad Laboratories, Inc.: Net Revenues, 2016-2019 ($Million), AGR %
Figure 284 Bio-Rad Laboratories, Inc.: Net Revenue (%) by Segment, 2019
Figure 285 Bio-Rad Laboratories, Inc.: Net Revenue (%) by Geography, 2019
1.1 Cell-Based Assays Market Segmentation
1.2 Why You Should Read This Report
1.3 What This Report Delivers
1.4 Key Questions Answered By This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.7 COVID-19 Impact: Recovery Scenarios
1.8 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQs)
1.10 Associated Reports
1.11 About Visiongain
2. Introduction to Cell-Based Assays
2.1 Cell-Based Assays Overview
2.2 Cost of New Drug Discovery and Development Reaches $1.5bn – Companies Constantly Looking for Increased Efficiencies
2.3 Drug Discovery Approaches – Target-Based and Phenotype-Based Discovery
2.4 Drug Screening Assays
2.5 Animal Models Present In Vivo Conditions: But Do Results Translate to Humans?
2.6 Biochemical Assays and their Advantages over Animal Models
2.7 Applications of Biochemical Assays
2.8 Lead Identification and Toxicity Testing
2.9 Cell-Based Assays and their Advantages
2.10 2D vs 3D Cell-Based Assays
2.11 Advanced Cell-Based Assays
2.12 The Different Assay Detection Methods and Technologies
2.13 Cells used in Cell-Based Assays
2.14 Immortalised Cell Lines – Convenient but not Truly Representative of Normal Human Cell Lines
2.15 Primary Cells: Closer to the In Vivo Environment
2.16 Stem Cells: Potential to Overcome Limitations of Primary cells and Immortalised Cell Lines
2.17 Uses for Cell-Based Assays in Drug Discovery and Development
2.18 High Throughput Screening: Greatly Increases Efficiency
3. Executive Summary
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Trends
4.5 SWOT Analysis of the Cell-Based Assays Market
4.6 STEP Analysis of the Cell-Based Assays Market
4.7 Porter’s Five Forces Analysis
5. COVID Impact: Cell-Based Assays Market 2020
6. Global Cell-Based Assays Market Forecast 2020-2030
6.1 Global Cell-based Assays Market Forecasts 2020-2030
6.2 Global Cell-based Assays Market: COVID-19 Recovery Revenue Forecasts (V, U, W, L) 2020-2030
7. Cell-Based Assays Market by Product: Forecasts 2020-2030
7.1 Global Instruments Market: Revenue Forecasts 2020-2030
7.1.1 Increasing Focus on Drug Discovery is Driving the Instruments Segment
7.2 Global Instruments Market: Recovery Revenue Forecasts (V, U, W, L)
7.2.1 Global Microplates Market: Revenue Forecast 2020-2030
7.2.2 Global Microplates Market: Recovery Revenue Forecasts (V, U, W, L)
7.2.3 Global Microplate Reader Market: Revenue Forecasts 2020-2030
7.2.4 Global Microplate Readers Market: Recovery Revenue Forecasts (V, U, W, L)
7.2.5 Global Liquid Handling System Market: Revenue Forecasts 2020-2030
7.2.6 Global Liquid Handling System Market: Recovery Revenue Forecasts (V, U, W, L)
7.3 Global Consumables Market: Revenue Forecasts 2020-2030
7.3.1 Surge of Investments in the Field of Pharmaceuticals and Drug Discovery
7.3.2 Global Consumables Market: Recovery Revenue Forecasts (V, U, W, L)
7.3.3 Global Reagents Market: Revenue Forecasts 2020-2030
7.3.3.1 .Global Reagents Market: Recovery Revenue Forecasts (V, U, W, L)
7.3.4 Global Assay Kits Market: Revenue Forecasts 2020-2030
7.3.4.1Global Assay Kits Market: Recovery Revenue Forecasts (V, U, W, L)
7.3.5 Global Cell Lines Market: Revenue Forecasts 2020-2030
7.3.6 Global Cell Lines Market: Recovery Revenue Forecasts (V, U, W, L)
7.3.7 Global Probes and Labels Market: Revenue Forecasts 2020-2030
7.3.8 Global Probes and Labels Market: Recovery Revenue Forecasts (V, U, W, L)
7.4 Global Software Market: Revenue Forecasts 2020-2030
7.4.1 Technological Advancement in the Software Segment boosting its Adoption
7.4.2 Global Software Market: Recovery Revenue Forecasts (V, U, W, L)
7.5 Global Services Market: Revenue Forecasts 2020-2030
7.5.1 Rising Outsourcing of Product R&D by Pharmaceutical & Biotechnology Companies
7.5.2 Global Services Market: Recovery Revenue Forecasts (V, U, W, L)
8. Cell-Based Assays Market by Technology: Forecasts 2020-2030
8.1 Global High Throughput Screening Market: Revenue Forecasts 2020-2030
8.1.1 HTS is Vital in drug R&D
8.1.2 Global High Throughput Screening Market: Recovery Revenue Forecasts (V, U, W, L)
8.2 Global Automated Liquid Handling Market: Revenue Forecasts 2020-2030
8.2.1 Rising Technological Advances in the Area of Automated Liquid Handing
8.2.2 Global Automated Liquid Handling Market: Recovery Revenue Forecasts (V, U, W, L)
8.3 Global Flow Cytometry Market: Revenue Forecasts 2020-2030
8.3.1 One of the Widely Used Technology in the Pharmaceutical & Biotechnology Industry
8.3.2 Global Flow Cytometry Market: Recovery Revenue Forecasts (V, U, W, L)
8.4 Global Label-Free Detection Market: Revenue Forecasts 2020-2030
8.4.1 Label-Free Detection Technology is a Promising Analytical Tool in Cell-Based Assays
8.4.2 Global Label-Free Detection Market: Recovery Revenue Forecasts (V, U, W, L)
9. Cell-Based Assays Market by Application: Forecasts 2020-2030
9.1 Global Drug Discovery Market: Revenue Forecasts 2020-2030
9.1.1 Recent Developments in the Cell-Based Assays for Drug Discovery is Propelling the Segment Growth
9.1.2 Global Drug Discovery Market: Recovery Revenue Forecasts (V, U, W, L)
9.2 Global Basic Research Market: Revenue Forecasts 2020-2030
9.2.1 Segment Growth
9.2.2 Global Basic Research Market: Recovery Revenue Forecasts (V, U, W, L)
9.3 Global Predictive Technology Market: Revenue Forecasts 2020-2030
9.3.1 Growing Demand for the Advanced Technologies for Disease Diagnosis and Drug Development
9.3.2 Global Predictive Technology Market: Recovery Revenue Forecasts (V, U, W, L)
9.4 Global ADME Market: Revenue Forecasts 2020-2030
9.4.1 Introduction of Technologically Advanced Computer-Based Testing Models
9.4.2 Global ADME Toxicity Testing Market: Recovery Revenue Forecasts (V, U, W, L)
10. Cell-Based Assays Market by End-User: Forecasts 2020-2030
10.1 Global Pharma & Biotech Companies Market: Revenue Forecasts 2020-2030
10.1.1 Largest Revenue Grossing Segment
10.1.2 Global Pharma & Biotech Companies Market: Recovery Revenue Forecasts (V, U, W, L)
10.2 Global Academic Institutions Market: Revenue Forecasts 2020-2030
10.2.1 One of The Fast Growing Segment
10.2.2 Global Academic Institutions Market: Recovery Revenue Forecasts (V, U, W, L)
10.3 Global Contract Research Organizations (CROs) Market: Revenue Forecasts 2020-2030
10.3.1 Pharmaceutical Outsourcing has witnessed a Significant Transformation over The Past Few Decades
10.3.2 Global Contract Research Organizations (CROs) Market: Recovery Revenue Forecasts (V, U, W, L)
11. Regional and Leading National Cell-Based Assays Market Forecasts 2020-2030
11.1 Regional Breakdown of the Global Cell-Based Assays Market, 2020-2030
11.2 Global Cell-Based Assays Market: Regional Forecast 2020-2030
11.3 North America Cell-Based Assays Revenue Forecast 2020-2030
11.3.1 Largest Revenue-Generating Regional Market
11.3.2 North America Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.3.3 The US Cell-Based Assays Revenue Forecast 2020-2030
11.3.4 U.S Dominated the North America Market
11.3.5 Stringent Demands for Safety Data from the FDA
11.3.6 US Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.3.7 Canada Cell-Based Assays Revenue Forecast 2020-2030
11.3.8 Canada is one of the leading locations for clinical trials for the pharma industry
11.3.9 Canada Pharmaceutical Market has an opportunity to flourish
11.3.10 Canada Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4 European Union (EU) Cell-Based Assays Market 2020-2030
11.4.1 Increasing Research Activities In European Region
11.4.2 Growing User Demand for Advanced Products In European Region
11.4.3 European Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.4 Europe National Market Share Breakdown, 2020, 2025 and 2030
11.4.5 European Market: Main National Market Forecasts, 2020-2030
11.4.6 German Cell-Based Assay Revenue Forecast, 2020-2030
11.4.7 Pharmaceutical companies in Germany are aggressively involved in drug development
11.4.8 German market will remain the largest in Europe
11.4.9 Germany Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.10 French Cell-Based Assays Revenue Forecast, 2020-2030
11.4.11 Research Institutes in France Focuses in collaboration with foreign institutions
11.4.12 Growing Adoption of Advanced technology
11.4.13 French Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.14 UK Cell-Based Assays Revenue Forecast, 2020-2030
11.4.15 Collaborations among the biotech companies in the UK
11.4.16 The UK is the third biggest cell-based assays
11.4.17 UK Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.18 Spanish Cell-Based Assays Revenue Forecast, 2020-2030
11.4.19 Spain is emerging as an important biotechnology hub in Europe
11.4.20 Rising Biotechnology Research Investment in Spain
11.4.21 Spanish Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.22 Italian Cell-Based Assays Revenue Forecast, 2020-2030
11.4.23 Partner research organizations and biotech start-ups involved in developing cell-based assay solutions and services
11.4.24 High demand for advanced medicines
11.4.25 Italian Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.26 Russia Cell-Based Assays Revenue Forecast, 2020-2030
11.4.27 Improving regulatory policies to develop the domestic pharmaceutical industry and Collaboration among Biotechnology Companies and Research Institutes
11.4.28 Russian Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.29 Sweden Cell-Based Assays Revenue Forecast, 2020-2030
11.4.30 Sweden’s pharmaceutical sector is becoming increasingly important to the country’s economy
11.4.31 Sweden is expected to acquire the seventh largest share of the European cell-based assays market
11.4.32 Sweden Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.33 Denmark Cell-Based Assays Revenue Forecast, 2020-2030
11.4.34 Denmark is an increasingly attractive location for businesses that depend on clinical trials
11.4.35 Many well-established Contract Research Organizations with expertise in setting up
11.4.36 Denmark Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.37 Finland Cell-Based Assays Revenue Forecast, 2020-2030
11.4.38 Finland has seen a dynamic bioscience industry spring up and it is one of the fast-growing markets
11.4.39 Finland Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.40 Norway Cell-Based Assays Revenue Forecast, 2020-2030
11.4.41 High Investment in the Healthcare Sector
11.4.42 The growing pharmaceutical industry in Norway
11.4.43 Norway Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.44 Rest of Europe Cell-Based Assays Revenue Forecast, 2020-2030
11.4.45 Rest of Europe Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.5 Asia-Pacific Cell-Based Assays Market 2020-2030
11.5.1 Asia Pacific Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.5.2 APAC Countries National Breakdown, 2020, 2025 and 2030
11.5.3 APAC Market National Forecasts, 2020-2030
11.5.4 Japanese Cell-Based Assays Revenue Forecast, 2020-2030
11.5.5 Japanese biotechnology and pharmaceutical companies focus on strategic collaborations
11.5.6 Japan has the world’s second-largest pharmaceutical market
11.5.7 Japanese Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.5.8 Chinese Cell-Based Assay Revenue Forecast, 2020-2030
11.5.9 One of the most important markets in the world
11.5.10 China is the second-largest cell-based assay market amongst the APAC Region
11.5.11 Chinese Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.5.12 Indian Cell-Based Assays Revenue Forecast, 2020-2030
11.5.13 India has been gaining increasing significance in the global drug R&D
11.5.14 India is an attractive market for pharmaceutical companies
11.5.15 Indian Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.5.16 Rest of APAC Cell-Based Assays Revenue Forecast, 2020-2030
11.5.17 Rest of APAC Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.6 LATAM Cell-Based Assays Market 2020-2030
11.6.1 Latin America Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.6.2 LATAM Countries National Breakdown, 2020, 2025 and 2030
11.6.3 LATAM Countries National Forecasts, 2020-2030
11.6.4 Brazilian Cell-Based Assays Revenue Forecast, 2020-2030
11.6.5 Investment by pharmaceutical & biotechnology companies in this region
11.6.6 Largest Market in Latin America
11.6.7 Brazilian Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.6.8 Mexico Cell-Based Assays Revenue Forecast, 2020-2030
11.6.9 Significant local production of active ingredients and finished products
11.6.10 Mexico has signed many Free Trade Agreements
11.6.11 Mexico Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.6.12 Rest of LATAM Cell-Based Assays Revenue Forecast, 2020-2030
11.6.13 Rest of LATAM Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.7 Middle-East & Africa (MEA) Cell-Based Assays Market 2020-2030
11.7.1 MEA Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
12. Leading Companies in the Cell-Based Assays Market, 2020-2030
12.1 DiscoverX Corporation (Eurofins DiscoverX)
12.2 Thermo Fisher Scientific
12.3 Cell Assay Innovations, Inc.
12.4 InSphero AG
12.5 QGel SA.
12.6 Becton, Dickinson and Company
12.7 Promega Corporation
12.8 BioVision, Inc.
12.9 Marin Biologic Laboratories
12.10 Molecular Devices, LLC. (Danaher Corporation)
12.11 Porsolt
12.12 CYTOO SA
12.13 Pharmaceutical Product Development, LLC.
12.14 ProQinase GmbH
12.15 Charles River Laboratories International, Inc.
12.16 BioAgilytix Labs
12.17 SGS Group
12.18 Perkin Elmer Inc.
12.19 General Electric Company (GE Healthcare)
12.20 F. Hoffmann-La Roche AG
12.21 Merck KGaA
12.22 Corning Inc.
12.23 Bio-Rad Laboratories
13. Cell-Based Assays Technology, Trends and Future Outlook
13.1 Stem Cells: Vast Potential
13.2 The Benefits of Using Stem Cells in Cell-Based Assays
13.3 iPSCs: An Uncontroversial and Abundant Source
13.4 Companies Providing Stem Cell-Based Assays
13.5 Toxicity Testing: Important Field for Cell-Based Assays
13.6 3D Systems: The Advantages of Next Generation of Cell Systems
13.7 Complexity of 3D Systems is a Challenge but many are reaching the Market
13.8 Organoids – The Future of Drug Development
13.9 Bio-Printing for Drug Development: Using 3D Printing Technology
13.10 Increasing Outsourcing of Cell-Based Assays
13.11 Label-Free Technology
13.12 GPCRs: A Common Drug and Drug Discovery Target
13.13 Allosteric GPCRs
13.14 Increasing Miniaturisation and Automation
13.15 Advantages of Miniaturisation
13.16 Advantages of Automation
13.17 Microfluids are Set to be a Trend
13.18 Multiplexing: Improves Efficiency of Cell-Based Assays
13.19 High Content Screening: A Well-Established Tool
13.20 Cell-Based Assays for the Development of Biologics
14. Conclusions
14.1 Growth Has Been Driven by Advantages of Cell-Based Assays
14.2 Current Status of the Market and its Growth Drivers
14.3 The Most Dominant National Markets and Emerging Countries
14.4 Future Trends and Technology
List of Tables
Table 1 Main Parameters Required in Drug Discovery and Development
Table 2 Selected Label-Free Detection Technologies Used for Cell-Based Assays
Table 3 Cell-Based Assays for HTS in Drug Screening
Table 4 Global Cell-based Assays Market, 2020-2030 (US$ million, CAGR %)
Table 5 Global Cell-based Assays Market Forecasts, 2020-2030 (US$ million, AGR %, CAGR %)
Table 6 “V” Shaped Recovery: Global Cell-based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 7 “U” Shaped Recovery: Global Cell-based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 8 “W” Shaped Recovery: Global Cell-based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 9 “L” Shaped Recovery: Global Cell-based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 10 Global Cell-based Assays Market Forecast by Product, 2020-2030 (US$ million, AGR %, CAGR %)
Table 11 Global Instruments Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 12 “V” Shaped Recovery: Global Instruments Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 13 “U” Shaped Recovery: Global Instruments Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 14 “W” Shaped Recovery: Global Instruments Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 18 “W” Shaped Recovery: Global Instruments Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Table 15 “L” Shaped Recovery: Global Instruments Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 16 Global Microplates Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 17 “V” Shaped Recovery: Global Microplates Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 18 “U” Shaped Recovery: Global Microplates Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 19 “W” Shaped Recovery: Global Microplates Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 20 “L” Shaped Recovery: Global Microplates Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 21 Global Microplate Readers Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 22 “V” Shaped Recovery: Global Microplate Readers Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 23 “U” Shaped Recovery: Global Microplate Readers Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 24 “W” Shaped Recovery: Global Microplate Readers Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 25 “L” Shaped Recovery: Global Microplate Readers Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 26 Global Liquid Handling System Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 27 “V” Shaped Recovery: Global Liquid Handling System Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 28 “U” Shaped Recovery: Global Liquid Handling System Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 29 “W” Shaped Recovery: Global Liquid Handling System Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 30 “L” Shaped Recovery: Global Liquid Handling System Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 31 Global Consumables Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 32 “V” Shaped Recovery: Global Consumables Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 33 “U” Shaped Recovery: Global Consumables Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 34 “W” Shaped Recovery: Global Consumables Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 35 “L” Shaped Recovery: Global Consumables Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 36 Global Reagents Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 37 “V” Shaped Recovery: Global Reagents Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 38 “U” Shaped Recovery: Global Reagents Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 40 “L” Shaped Recovery: Global Reagents Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 44 “L” Shaped Recovery: Global Reagents Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Table 41 Global Assay Kits Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 42 “V” Shaped Recovery: Global Assay Kits Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 43 “U” Shaped Recovery: Global Assay Kits Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 44 “W” Shaped Recovery: Global Assay Kits Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 45 “L” Shaped Recovery: Global Assay Kits Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 46 Global Cell Lines Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 47 “V” Shaped Recovery: Global Cell Lines Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 48 “U” Shaped Recovery: Global Cell Lines Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 49 “W” Shaped Recovery: Global Cell Lines Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 50 “L” Shaped Recovery: Global Cell Lines Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 51 Global Probes and Labels Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 52 “V” Shaped Recovery: Global Probes and Labels Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 53 “U” Shaped Recovery: Global Probes and Labels Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 54 “W” Shaped Recovery: Global Probes and Labels Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 55 “L” Shaped Recovery: Global Probes and Labels Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 56 Global Software Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 57 “V” Shaped Recovery: Global Software Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 58 “U” Shaped Recovery: Global Software Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 59 “W” Shaped Recovery: Global Software Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 60 “L” Shaped Recovery: Global Software Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 61 Global Services Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 62 “V” Shaped Recovery: Global Services Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 63 “U” Shaped Recovery: Global Services Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 64 “W” Shaped Recovery: Global Services Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 65 “L” Shaped Recovery: Global Services Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 66 Global Cell-based Assays Market Forecast by Technology, 2020-2030 (US$ million, AGR %, CAGR %)
Table 67 Global High Throughput Screening Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 68 “V” Shaped Recovery: Global High Throughput Screening Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 69 “U” Shaped Recovery: Global High Throughput Screening Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 70 “W” Shaped Recovery: Global High Throughput Screening Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 71 “L” Shaped Recovery: Global High Throughput Screening Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 72 Global Automated Liquid Handling Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 73 “V” Shaped Recovery: Global Automated Liquid Handling Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 74 “U” Shaped Recovery: Global Automated Liquid Handling Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 75 “W” Shaped Recovery: Global Automated Liquid Handling Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 76 “L” Shaped Recovery: Global Automated Liquid Handling Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 77 Global Flow Cytometry Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 78 “V” Shaped Recovery: Global Flow Cytometry Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 79 “U” Shaped Recovery: Global Flow Cytometry Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 80 “W” Shaped Recovery: Global Flow Cytometry Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 81 “L” Shaped Recovery: Global Flow Cytometry Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 82 Global Label-Free Detection Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 83 “V” Shaped Recovery: Global Label-Free Detection Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 84 “U” Shaped Recovery: Global Label-Free Detection Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 85 “W” Shaped Recovery: Global Label-Free Detection Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 86 “L” Shaped Recovery: Global Label-Free Detection Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 87 Global Cell-based Assays Market Forecast by Application, 2020-2030 (US$ million, AGR %, CAGR %)
Table 88 Global Drug Discovery Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 89 “V” Shaped Recovery: Global Drug Discovery Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 90 “U” Shaped Recovery: Global Drug Discovery Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 94 “U” Shaped Recovery: Global Drug Discovery Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 95 “W” Shaped Recovery: Global Drug Discovery Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 97 “L” Shaped Recovery: Global Drug Discovery Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 99 Global Basic Research Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 101 “V” Shaped Recovery: Global Basic Research Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 103 “U” Shaped Recovery: Global Basic Research Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 105 “W” Shaped Recovery: Global Basic Research Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 107 “L” Shaped Recovery: Global Basic Research Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 109 Global Predictive Technology Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 111 “V” Shaped Recovery: Global Predictive Technology Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 113 “U” Shaped Recovery: Global Predictive Technology Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 115 “W” Shaped Recovery: Global Predictive Technology Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 118 Global ADME Toxicity Testing Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Figure 121 “U” Shaped Recovery: Global ADME Toxicity Testing Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 95 Global Cell-based Assays Market Forecast by End-User, 2020-2030 (US$ million, AGR %, CAGR %)
Table 96 Global Pharma & Biotech Companies Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 97 “V” Shaped Recovery: Global Pharma & Biotech Companies Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 98 “U” Shaped Recovery: Global Pharma & Biotech Companies Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 99 “W” Shaped Recovery: Global Pharma & Biotech Companies Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 100 “L” Shaped Recovery: Global Pharma & Biotech Companies Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 101 Global Academic Institutions Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 102 “V” Shaped Recovery: Global Academic Institutions Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 103 “U” Shaped Recovery: Global Academic Institutions Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 104 “W” Shaped Recovery: Global Academic Institutions Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 105 “L” Shaped Recovery: Global Academic Institutions Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 106 Global Contract Research Organizations (CROs) Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 107 “V” Shaped Recovery: Global Contract Research Organizations (CROs) Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 108 “U” Shaped Recovery: Global Contract Research Organizations (CROs) Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 109 “W” Shaped Recovery: Global Contract Research Organizations (CROs) Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 110 “L” Shaped Recovery: Global Contract Research Organizations (CROs) Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 111 Global Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2020, 2025, & 2030
Table 112 Global Cell-based Assays Market Forecast by Region, 2020-2030 (US$ million, AGR %, CAGR %)
Table 113 North America Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 115 “U” Shaped Recovery: North America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 116 “W” Shaped Recovery: North America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 117 “L” Shaped Recovery: North America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 118 US Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 119 “V” Shaped Recovery: US Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 120 “U” Shaped Recovery: US Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 121 “W” Shaped Recovery: US Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 122 “L” Shaped Recovery: US Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 123 Canada Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 125 “U” Shaped Recovery: Canada Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 126 “W” Shaped Recovery: Canada Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 127 “L” Shaped Recovery: Canada Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 128 European Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 129 “V” Shaped Recovery: European Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 130 “U” Shaped Recovery: European Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 131 “W” Shaped Recovery: European Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 132 “L” Shaped Recovery: European Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 134 Europe Cell-based Assays Market Forecast by Region, 2020-2030 (US$ million, AGR %, CAGR %)
Table 135 Germany Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 136 “V” Shaped Recovery: Germany Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 137 “U” Shaped Recovery: Germany Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 138 “W” Shaped Recovery: Germany Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 139 “L” Shaped Recovery: Germany Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 140 French Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 141 “V” Shaped Recovery: French Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 142 “U” Shaped Recovery: French Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 143 “W” Shaped Recovery: French Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 144 “L” Shaped Recovery: French Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 167 “U” Shaped Recovery: Sweden Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 168 “W” Shaped Recovery: Sweden Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 169 “L” Shaped Recovery: Sweden Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 170 Denmark Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 171 “V” Shaped Recovery: Denmark Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 172 “U” Shaped Recovery: Denmark Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 173 “W” Shaped Recovery: Denmark Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 174 “L” Shaped Recovery: Denmark Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 175 “L” Shaped Recovery: Denmark Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Table 176 Finland Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 177 “V” Shaped Recovery: Finland Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 178 “U” Shaped Recovery: Finland Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 179 “W” Shaped Recovery: Finland Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 180 “L” Shaped Recovery: Finland Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 181 Norway Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 182 “V” Shaped Recovery: Norway Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 183 “U” Shaped Recovery: Norway Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 184 “W” Shaped Recovery: Norway Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 185 “L” Shaped Recovery: Norway Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 186 “L” Shaped Recovery: Norway Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Table 187 Rest of Europe Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 188 Rest of Europe Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Table 189 “V” Shaped Recovery: Rest of Europe Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 190 “U” Shaped Recovery: Rest of Europe Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 191 “W” Shaped Recovery: Rest of Europe Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 192 “L” Shaped Recovery: Rest of Europe Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 193 Asia Pacific Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 194 “V” Shaped Recovery: Asia Pacific Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 195 “U” Shaped Recovery: Asia Pacific Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 196 “W” Shaped Recovery: Asia Pacific Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 197 “L” Shaped Recovery: Asia Pacific Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 198 Asia Pacific Cell-based Assays Market Forecast by Region, 2020-2030 (US$ million, AGR %, CAGR %)
Table 199 Japanese Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 200 “V” Shaped Recovery: Japanese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 201 “U” Shaped Recovery: Japanese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 202 “W” Shaped Recovery: Japanese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 203 “L” Shaped Recovery: Japanese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 204 Chinese Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 205 “V” Shaped Recovery: Chinese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 206 “U” Shaped Recovery: Chinese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 207 “W” Shaped Recovery: Chinese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 208 “L” Shaped Recovery: Chinese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 209 Indian Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 210 “V” Shaped Recovery: Indian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 211 “U” Shaped Recovery: Indian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 212 “W” Shaped Recovery: Indian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 213 “L” Shaped Recovery: Indian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 214 Rest of APAC Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 215 “V” Shaped Recovery: Rest of APAC Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 216 “U” Shaped Recovery: Rest of APAC Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 217 “W” Shaped Recovery: Rest of APAC Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 218 “L” Shaped Recovery: Rest of APAC Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 219 Latin America Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 220 “V” Shaped Recovery: Latin America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 221 “U” Shaped Recovery: Latin America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 222 “W” Shaped Recovery: Latin America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 223 “L” Shaped Recovery: Latin America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 225 Latin America Cell-based Assays Market Forecast by Region, 2020-2030 (US$ million, AGR %, CAGR %)
Table 226 Brazilian Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 227 “V” Shaped Recovery: Brazilian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 228 “U” Shaped Recovery: Brazilian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 229 “W” Shaped Recovery: Brazilian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 230 “L” Shaped Recovery: Brazilian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 231 Mexico Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 232 “V” Shaped Recovery: Mexico Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 233 “U” Shaped Recovery: Mexico Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 234 “W” Shaped Recovery: Mexico Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 235 “L” Shaped Recovery: Mexico Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 236 Rest of LATAM Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 237 “V” Shaped Recovery: Rest of LATAM Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 238 “U” Shaped Recovery: Rest of LATAM Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 239 “W” Shaped Recovery: Rest of LATAM Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 240 “L” Shaped Recovery: Rest of LATAM Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 241 MEA Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 242 “V” Shaped Recovery: MEA Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 244 “W” Shaped Recovery: MEA Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 245 “L” Shaped Recovery: MEA Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%, CAGR%)
Table 246 Eurofins DiscoverX: Company Profile
Table 247 DiscoverX: Cell-based Assay Product Portfolio
Table 248 Thermo Fisher Scientific, Inc.: Company Profile
Table 249 Thermo Fisher Scientific, Inc.: Cell-based Assay Product Portfolio
Table 250 Thermo Fisher Scientific: Net Revenues, 2016-2019 ($Million)
Table 251 Cell Assay Innovations, Inc.: Company Profile
Table 253 InSphero AG: Company Profile
Table 254 InSphero AG: Cell-based Assay Product Portfolio
Table 255 QGel SA.: Company Profile
Table 256 QGel SA.: Cell-based Assay Product Portfolio
Table 257 Becton, Dickinson and Company: Company Profile
Table 258 Becton, Dickinson and Company: Cell-based Assay Product Portfolio
Table 261 BioVision, Inc.: Company Profile
Table 262 BioVision, Inc.: Cell-based Assay Product Portfolio
Table 263 Marin Biologic Laboratories: Company Profile
Table 264 Marin Biologic Laboratories: Cell-based Assay Product Portfolio
Table 265 Molecular Devices, LLC.: Company Profile
Table 266 Molecular Devices, LLC.: Cell-based Assay Product Portfolio
Table 267 Porsolt: Company Profile
Table 268 Porsolt: Cell-based Assay Product Portfolio
Table 269 CYTOO SA: Company Profile
Table 270 CYTOO SA: Cell-based Assay Product Portfolio
Table 271 Pharmaceutical Product Development, LLC.: Company Profile
Table 272 Pharmaceutical Product Development, LLC.: Cell-based Assay Product Portfolio
Table 273 ProQinase GmbH: Company Profile
Table 274 ProQinase GmbH: Cell-based Assay Product Portfolio
Table 275 Charles River Laboratories International, Inc.: Company Profile
Table 276 Charles River Laboratories International, Inc.: Cell-based Assay Product Portfolio
Table 277 BioAgilytix Labs: Company Profile
Table 278 BioAgilytix Labs: Cell-based Assay Product Portfolio
Table 279 SGS Group: Company Profile
Table 280 SGS Group: Cell-based Assay Product Portfolio
Table 281 Perkin Elmer Inc.: Company Profile
Table 282 Perkin Elmer Inc.: Cell-based Assay Product Portfolio
Table 283 General Electric: Company Profile
Table 285 F. Hoffmann-La Roche AG: Company Profile
Table 286 F. Hoffmann-La Roche AG: Cell-based Assay Product Portfolio
Table 287 Merck KGaA: Company Profile
Table 288 Merck KGaA: Cell-based Assay Product Portfolio
Table 289 Corning Inc.: Company Profile
Table 290 Corning Inc.: Cell-based Assay Product Portfolio
Table 291 Bio-Rad Laboratories, Inc.: Company Profile
Table 292 Bio-Rad Laboratories, Inc.: Cell-based Assay Product Portfolio
Table 294 Selected Companies Offering Label-Free Assay Systems
List of Figures
Figure 1 Global Cell-based Assays Market Segmentation
Figure 2 Stages of Pre-Clinical Drug Development
Figure 3 Global Cell-based Assays Market Overview,2020
Figure 4 Estimated number of new lung cancer cases worldwide, 2012-2030
Figure 5 Estimated number of new pancreatic cancer cases worldwide, 2012-2030
Figure 6 Strengths and Weaknesses of the Cell-Based Assay Market, 2020
Figure 7 PEST Analysis, 2020
Figure 8 Porter’s Five Forces Analysis,2020
Figure 9 Global Cell-based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR %)
Figure 10 “V” Shaped Recovery: Global Cell-based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR %)
Figure 11 “U” Shaped Recovery: Global Cell-based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR %)
Figure 12 “W” Shaped Recovery: Global Cell-based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR %)
Figure 13 “L” Shaped Recovery: Global Cell-based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR %)
Figure 14 Global Cell-based Assays Market Share Forecast by Product, 2020, 2025, 2030 (%)
Figure 15 Global Instruments Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 16 “V” Shaped Recovery: Global Instruments Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 17 “U” Shaped Recovery: Global Instruments Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 18 “W” Shaped Recovery: Global Instruments Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 19 “L” Shaped Recovery: Global Instruments Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 20 Global Microplates Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 21 “V” Shaped Recovery: Global Microplates Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 22 “U” Shaped Recovery: Global Microplates Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 23 “W” Shaped Recovery: Global Microplates Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 24 “L” Shaped Recovery: Global Microplates Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 25 Global Microplate Readers Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 26 “V” Shaped Recovery: Global Microplate Readers Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 27 “U” Shaped Recovery: Global Microplate Readers Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 28 “W” Shaped Recovery: Global Microplate Readers Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 29 “L” Shaped Recovery: Global Microplate Readers Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 30 Global Liquid Handling System Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 31 “V” Shaped Recovery: Global Liquid Handling System Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 32 “U” Shaped Recovery: Global Liquid Handling System Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 33 “W” Shaped Recovery: Global Liquid Handling System Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 34 “L” Shaped Recovery: Global Liquid Handling System Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 35 Global Consumables Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 36 “V” Shaped Recovery: Global Consumables Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 37 “U” Shaped Recovery: Global Consumables Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 38 “W” Shaped Recovery: Global Consumables Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 39 “L” Shaped Recovery: Global Consumables Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 40 Global Reagents Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 41 “V” Shaped Recovery: Global Reagents Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 42 “U” Shaped Recovery: Global Reagents Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 43 “W” Shaped Recovery: Global Reagents Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 44 “L” Shaped Recovery: Global Reagents Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 45 Global Assay Kits Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 46 “V” Shaped Recovery: Global Assay Kits Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 47 “U” Shaped Recovery: Global Assay Kits Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 48 “W” Shaped Recovery: Global Assay Kits Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 49 “L” Shaped Recovery: Global Assay Kits Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 50 Global Cell Lines Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 51 “V” Shaped Recovery: Global Cell Lines Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 52 “U” Shaped Recovery: Global Cell Lines Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 53 “W” Shaped Recovery: Global Cell Lines Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 54 “L” Shaped Recovery: Global Cell Lines Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 55 Global Probes and Labels Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 56 “V” Shaped Recovery: Global Probes and Labels Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 57 “U” Shaped Recovery: Global Probes and Labels Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 58 “W” Shaped Recovery: Global Probes and Labels Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 59 “L” Shaped Recovery: Global Probes and Labels Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 60 Global Softwares Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 61 “V” Shaped Recovery: Global Softwares Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 62 “U” Shaped Recovery: Global Softwares Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 63 “W” Shaped Recovery: Global Softwares Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 64 “L” Shaped Recovery: Global Softwares Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 65 Global Services Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 66 “V” Shaped Recovery: Global Services Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 67 “U” Shaped Recovery: Global Services Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 68 “W” Shaped Recovery: Global Services Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 69 “L” Shaped Recovery: Global Services Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 70 Global Cell-based Assays Market Share Forecast by Technology, 2020, 2025, 2030 (%)
Figure 71 Global High Throughput Screening Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 72 “V” Shaped Recovery: Global High Throughput Screening Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 73 “U” Shaped Recovery: Global High Throughput Screening Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 74 “W” Shaped Recovery: Global High Throughput Screening Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 75 “L” Shaped Recovery: Global High Throughput Screening Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 76 Global Automated Liquid Handling Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 77 “V” Shaped Recovery: Global Automated Liquid Handling Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 78 “U” Shaped Recovery: Global Automated Liquid Handling Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 79 “W” Shaped Recovery: Global Automated Liquid Handling Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 80 “L” Shaped Recovery: Global Automated Liquid Handling Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 81 Global Flow Cytometry Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 82 “V” Shaped Recovery: Global Flow Cytometry Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 83 “U” Shaped Recovery: Global Flow Cytometry Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 84 “W” Shaped Recovery: Global Flow Cytometry Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 85 “L” Shaped Recovery: Global Flow Cytometry Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 86 Global Label-Free Detection Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 87 “V” Shaped Recovery: Global Label-Free Detection Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 88 “U” Shaped Recovery: Global Label-Free Detection Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 89 “W” Shaped Recovery: Global Label-Free Detection Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 90 “L” Shaped Recovery: Global Label-Free Detection Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 91 Global Cell-based Assays Market Share Forecast by Application, 2020, 2025, 2030 (%)
Figure 92 Global Drug Discovery Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 93 “V” Shaped Recovery: Global Drug Discovery Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 94 “U” Shaped Recovery: Global Drug Discovery Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 95 “W” Shaped Recovery: Global Drug Discovery Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 96 “L” Shaped Recovery: Global Drug Discovery Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 97 Global Basic Research Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 98 “V” Shaped Recovery: Global Basic Research Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 99 “U” Shaped Recovery: Global Basic Research Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 100 “W” Shaped Recovery: Global Basic Research Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 101 “L” Shaped Recovery: Global Basic Research Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 102 Global Predictive Technology Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 103 “V” Shaped Recovery: Global Predictive Technology Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 104 “U” Shaped Recovery: Global Predictive Technology Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 105 “W” Shaped Recovery: Global Predictive Technology Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 106 “L” Shaped Recovery: Global Predictive Technology Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 107 Global ADME Toxicity Testing Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 108 “V” Shaped Recovery: Global ADME Toxicity Testing Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 109 “U” Shaped Recovery: Global ADME Toxicity Testing Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 110 “W” Shaped Recovery: Global ADME Toxicity Testing Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 111 “L” Shaped Recovery: Global ADME Toxicity Testing Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 112 Global Cell-based Assays Market Share Forecast by End-User, 2020, 2025, 2030 (%)
Figure 113 Global Pharma & Biotech Companies Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 114 “V” Shaped Recovery: Global Pharma & Biotech Companies Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 115 “U” Shaped Recovery: Global Pharma & Biotech Companies Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 116 “W” Shaped Recovery: Global Pharma & Biotech Companies Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 117 “L” Shaped Recovery: Global Pharma & Biotech Companies Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 118 Global Academic Institutions Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 119 “V” Shaped Recovery: Global Academic Institutions Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 120 “U” Shaped Recovery: Global Academic Institutions Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 121 “W” Shaped Recovery: Global Academic Institutions Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 122 “L” Shaped Recovery: Global Academic Institutions Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 123 Global Contract Research Organizations (CROs) Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 124 “V” Shaped Recovery: Global Contract Research Organizations (CROs) Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 125 “U” Shaped Recovery: Global Contract Research Organizations (CROs) Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 126 “W” Shaped Recovery: Global Contract Research Organizations (CROs) Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 127 “L” Shaped Recovery: Global Contract Research Organizations (CROs) Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 128 Global Cell-Based Assays Market Forecast by Region 2020, 2025, & 2030 (% Share)
Figure 129 North America Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 130 “V” Shaped Recovery: North America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 131 “U” Shaped Recovery: North America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 132 “W” Shaped Recovery: North America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 133 “L” Shaped Recovery: North America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 134 US Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 135 “V” Shaped Recovery: US Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 136 “U” Shaped Recovery: US Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 137 “W” Shaped Recovery: US Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 138 “L” Shaped Recovery: US Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 139 Canada Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 140 “V” Shaped Recovery: Canada Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 141 “U” Shaped Recovery: Canada Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 142 “W” Shaped Recovery: Canada Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 143 “L” Shaped Recovery: Canada Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 144 European Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 145 “V” Shaped Recovery: European Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 146 “U” Shaped Recovery: European Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 147 “W” Shaped Recovery: European Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 148 “L” Shaped Recovery: European Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 149 Germany Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 150 “V” Shaped Recovery: Germany Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 151 “U” Shaped Recovery: Germany Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 152 “W” Shaped Recovery: Germany Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 153 “L” Shaped Recovery: Germany Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 154 French Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 155 “V” Shaped Recovery: French Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 156 “U” Shaped Recovery: French Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 157 “W” Shaped Recovery: French Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 158 “L” Shaped Recovery: French Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 159 UK Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 160 “V” Shaped Recovery: UK Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 161 “U” Shaped Recovery: UK Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 162 “W” Shaped Recovery: UK Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 163 “L” Shaped Recovery: UK Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 164 Spanish Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 165 “V” Shaped Recovery: Spanish Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 166 “U” Shaped Recovery: Spanish Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 167 “W” Shaped Recovery: Spanish Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 168 “L” Shaped Recovery: Spanish Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 169 Italian Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 170 “V” Shaped Recovery: Italian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 171 “U” Shaped Recovery: Italian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 172 “W” Shaped Recovery: Italian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 173 “L” Shaped Recovery: Italian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 174 Russian Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 175 “V” Shaped Recovery: Russian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 176 “U” Shaped Recovery: Russian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 177 “W” Shaped Recovery: Russian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 178 “L” Shaped Recovery: Russian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 179 Sweden Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 180 “V” Shaped Recovery: Sweden Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 181 “U” Shaped Recovery: Sweden Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 182 “W” Shaped Recovery: Sweden Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 183 “L” Shaped Recovery: Sweden Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 184 Denmark Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 185 “V” Shaped Recovery: Denmark Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 186 “U” Shaped Recovery: Denmark Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 187 “W” Shaped Recovery: Denmark Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 188 “L” Shaped Recovery: Denmark Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 189 Finland Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 190 “V” Shaped Recovery: Finland Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 191 “U” Shaped Recovery: Finland Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 192 “W” Shaped Recovery: Finland Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 193 “L” Shaped Recovery: Finland Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 194 Norway Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 195 “V” Shaped Recovery: Norway Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 196 “U” Shaped Recovery: Norway Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 197 “W” Shaped Recovery: Norway Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 198 “L” Shaped Recovery: Norway Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 199 Rest of Europe Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 200 “V” Shaped Recovery: Rest of Europe Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 201 “U” Shaped Recovery: Rest of Europe Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 202 “W” Shaped Recovery: Rest of Europe Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 203 “L” Shaped Recovery: Rest of Europe Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 204 Asia Pacific Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 205 “V” Shaped Recovery: Asia Pacific Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 206 “U” Shaped Recovery: Asia Pacific Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 207 “W” Shaped Recovery: Asia Pacific Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 208 “L” Shaped Recovery: Asia Pacific Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 209 Asia Pacific Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2020, 2025, & 2030
Figure 210 Japanese Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 211 “V” Shaped Recovery: Japanese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 212 “U” Shaped Recovery: Japanese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 213 “W” Shaped Recovery: Japanese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 214 “L” Shaped Recovery: Japanese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 215 Chinese Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 216 “V” Shaped Recovery: Chinese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 217 “U” Shaped Recovery: Chinese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 218 “W” Shaped Recovery: Chinese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 219 “L” Shaped Recovery: Chinese Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 220 Indian Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 221 “V” Shaped Recovery: Indian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 222 “U” Shaped Recovery: Indian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 223 “W” Shaped Recovery: Indian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 224 “L” Shaped Recovery: Indian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 225 Rest of APAC Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 226 “V” Shaped Recovery: Rest of APAC Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 227 “U” Shaped Recovery: Rest of APAC Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 228 “W” Shaped Recovery: Rest of APAC Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 229 “L” Shaped Recovery: Rest of APAC Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 230 Latin America Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 231 “V” Shaped Recovery: Latin America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 232 “U” Shaped Recovery: Latin America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 233 “W” Shaped Recovery: Latin America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 234 “L” Shaped Recovery: Latin America Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 235 Brazilian Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 236 “V” Shaped Recovery: Brazilian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 237 “U” Shaped Recovery: Brazilian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 238 “W” Shaped Recovery: Brazilian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 239 “L” Shaped Recovery: Brazilian Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 240 Mexico Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 241 “V” Shaped Recovery: Mexico Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 242 “U” Shaped Recovery: Mexico Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 243 “W” Shaped Recovery: Mexico Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 244 “L” Shaped Recovery: Mexico Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 245 Rest of LATAM Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 246 “V” Shaped Recovery: Rest of LATAM Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 247 “U” Shaped Recovery: Rest of LATAM Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 248 “W” Shaped Recovery: Rest of LATAM Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 249 “L” Shaped Recovery: Rest of LATAM Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 250 MEA Cell-Based Assays Market: Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 251 “V” Shaped Recovery: MEA Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 252 “U” Shaped Recovery: MEA Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 253 “W” Shaped Recovery: MEA Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 254 “L” Shaped Recovery: MEA Cell-Based Assays Market, Revenue Forecasts 2020-2030 (US$ million, AGR%)
Figure 255 Thermo Fisher Scientific: Net Revenues, 2016-2019 ($Million)
Figure 256 Thermo Fisher Scientific: Net Revenue (%) by Segment, 2019
Figure 257 Thermo Fisher Scientific: Net Revenue (%) by Geography, 2019
Figure 258 BD: Net Revenues ($Million) & AGR (%), 2016-2019
Figure 259 BD: Net Revenue (%) by Segment, 2019
Figure 260 BD: Net Revenue (%) by Geography, 2019
Figure 261 Danaher Corporation: Net Revenues, 2016-2019 ($Million), AGR %
Figure 262 Danaher Corporation: Net Revenue (%) by Segment, 2019
Figure 263 Danaher Corporation: Net Revenue (%) by Geography, 2019
Figure 264 Charles River Laboratories: Net Revenues, 2016-2019 ($Million), AGR %
Figure 265 Charles River Laboratories: Net Revenue (%) by Segment, 2019
Figure 266 Charles River Laboratories: Net Revenue (%) by Geography, 2019
Figure 267 SGS Group: Net Revenues, 2016-2019 ($Million), AGR %
Figure 268 SGS Group: Net Revenue (%) by Segment, 2019
Figure 269 SGS Group: Net Revenue (%) by Geography, 2019
Figure 270 Perkin Elmer Inc.: Net Revenues, 2016-2019 ($Million), AGR %
Figure 271 Perkin Elmer: Segment Revenues, 2019 (%)
Figure 272 Perkin Elmer: Regional Revenues, 2019 (%)
Figure 273 GE Healhcare: Net Revenues, 2016-2019 ($Million), AGR %
Figure 274 F. Hoffmann-La Roche AG: Net Revenues, 2016-2019 ($Million), AGR %
Figure 275 F. Hoffmann-La Roche AG: Net Revenue (%) by Segment, 2019
Figure 276 F. Hoffmann-La Roche AG: Net Revenue (%) by Geography, 2019
Figure 277 Merck KGaA: Net Revenues, 2016-2019 ($Million), AGR %
Figure 278 Merck KGaA: Net Revenue (%) by Segment, 2019
Figure 279 Merck KGaA: Net Revenue (%) by Geography, 2019
Figure 280 Corning Inc.: Net Revenues, 2016-2019 ($Million), AGR %
Figure 281 Corning Inc.: Net Revenue (%) by Segment, 2019
Figure 282 Corning Inc.: Net Revenue (%) by Geography, 2019
Figure 283 Bio-Rad Laboratories, Inc.: Net Revenues, 2016-2019 ($Million), AGR %
Figure 284 Bio-Rad Laboratories, Inc.: Net Revenue (%) by Segment, 2019
Figure 285 Bio-Rad Laboratories, Inc.: Net Revenue (%) by Geography, 2019
Companies Profiled in the Report:
Becton, Dickinson and Company
Bio-Rad Laboratories
BioAgilytix Labs
BioVision, Inc.
Cell Assay Innovations, Inc.
Charles River Laboratories International, Inc.
Corning Inc.
CYTOO SA
DiscoverX Corporation (Eurofins DiscoverX)
F. Hoffmann-La Roche AG
General Electric Company (GE Healthcare)
InSphero AG
Marin Biologic Laboratories
Merck KGaA
Molecular Devices, LLC. (Danaher Corporation)
Perkin Elmer Inc.
Pharmaceutical Product Development, LLC.
Porsolt
Promega Corporation
ProQinase GmbH
QGel SA.
SGS Group
Thermo Fisher Scientific
List of Companies Mentioned in the Report:
Accenture’s Life Sciences
Agilent
Ametek Inc.
Axiogenesis
Beckman Coulter, Inc.
Becton Dickinson (BD)
Bio Engineering Laboratory
Biofungitek,
Cellomics
Cellular Dynamics
Clontech (Takara Bio)
Corning
CSL Limited
CXR Biosciences
Danaher Corp.
Diagnosticos da America (DASA) SA
Dr. Reddy’s Laboratories
Draconis Pharma,
ESI BIO (Bio Time)
HalioDx SAS
Innoprot,
InSphero AG
Interchim
Jubilant Biosys
LABTECH
Likarda
Maxcyte
METTLER TOLEDO
Molecular Devices, LLC
Neuron BioServices,
Organovo
PerkinElmer
Premas Lifescience
Promega Corporation
ReNeuron
ReproCELL
Rigaku Corp.
Sartorius
SGS Group
Spheroid
Straub Medical AG
Tecan
Tecan Group Ltd.
VelaLabs
VitoTag Biosciences,
ZF BioLabs
ZF Biotox
List of Organizations Mentioned in the Report:
All India Institute of Medical Sciences (AIIMS)
AMR Centre (AMRC)
Association of Research-Based Pharmaceutical Companies
AXAM - innovative Partner Research Organization (iPRO)
Bergen Marine Research Cluster, Norway
Biotechnology Industry Research Assistance Council (BIRAC)
Cellular Dynamics International
Department of Biotechnology (DBT), Government of India
Food and Drug Administration (FDA)
Hubrecht Institute
Indian Institute of Chemical Technology (IICT)
Institute for Chemical Sciences in Rennes
Japan’s Institute of Biomedical Research
Ministry of Health of Norway
National Health Service (NHS)
National Technology Agency, Tekes
Organization for Economic Cooperation and Development (OECD)
Oslo Cancer Cluster, Norway
Pharmaceutical Research and Manufacturers of America (PhRMA)
Regional Research Funding Institution, Brazil
Russian science and technology organisation
Shinya Yamanaka at the University of Kyoto
The Di Carlo Laboratory, UCLA
The Skolkovo Foundation
World Health Organization (WHO)
Becton, Dickinson and Company
Bio-Rad Laboratories
BioAgilytix Labs
BioVision, Inc.
Cell Assay Innovations, Inc.
Charles River Laboratories International, Inc.
Corning Inc.
CYTOO SA
DiscoverX Corporation (Eurofins DiscoverX)
F. Hoffmann-La Roche AG
General Electric Company (GE Healthcare)
InSphero AG
Marin Biologic Laboratories
Merck KGaA
Molecular Devices, LLC. (Danaher Corporation)
Perkin Elmer Inc.
Pharmaceutical Product Development, LLC.
Porsolt
Promega Corporation
ProQinase GmbH
QGel SA.
SGS Group
Thermo Fisher Scientific
List of Companies Mentioned in the Report:
Accenture’s Life Sciences
Agilent
Ametek Inc.
Axiogenesis
Beckman Coulter, Inc.
Becton Dickinson (BD)
Bio Engineering Laboratory
Biofungitek,
Cellomics
Cellular Dynamics
Clontech (Takara Bio)
Corning
CSL Limited
CXR Biosciences
Danaher Corp.
Diagnosticos da America (DASA) SA
Dr. Reddy’s Laboratories
Draconis Pharma,
ESI BIO (Bio Time)
HalioDx SAS
Innoprot,
InSphero AG
Interchim
Jubilant Biosys
LABTECH
Likarda
Maxcyte
METTLER TOLEDO
Molecular Devices, LLC
Neuron BioServices,
Organovo
PerkinElmer
Premas Lifescience
Promega Corporation
ReNeuron
ReproCELL
Rigaku Corp.
Sartorius
SGS Group
Spheroid
Straub Medical AG
Tecan
Tecan Group Ltd.
VelaLabs
VitoTag Biosciences,
ZF BioLabs
ZF Biotox
List of Organizations Mentioned in the Report:
All India Institute of Medical Sciences (AIIMS)
AMR Centre (AMRC)
Association of Research-Based Pharmaceutical Companies
AXAM - innovative Partner Research Organization (iPRO)
Bergen Marine Research Cluster, Norway
Biotechnology Industry Research Assistance Council (BIRAC)
Cellular Dynamics International
Department of Biotechnology (DBT), Government of India
Food and Drug Administration (FDA)
Hubrecht Institute
Indian Institute of Chemical Technology (IICT)
Institute for Chemical Sciences in Rennes
Japan’s Institute of Biomedical Research
Ministry of Health of Norway
National Health Service (NHS)
National Technology Agency, Tekes
Organization for Economic Cooperation and Development (OECD)
Oslo Cancer Cluster, Norway
Pharmaceutical Research and Manufacturers of America (PhRMA)
Regional Research Funding Institution, Brazil
Russian science and technology organisation
Shinya Yamanaka at the University of Kyoto
The Di Carlo Laboratory, UCLA
The Skolkovo Foundation
World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Cell-Based Assays Market Report to 2030Related reports
-
Therapeutic Respiratory Devices Market Report 2021-2031
The worldwide demand for therapeutic respiratory devices market is anticipated to grow on account of rising burden of respiratory diseases,...Full DetailsPublished: 26 April 2021 -
Antibody Drug Conjugates Market Report 2021-2031
Antibody drug conjugate (ADC) technology continues to evolve as a widely successful drug targeting technology for the treatment of cancer....
Full DetailsPublished: 03 November 2020 -
Enteric Soft Gel Capsules Market Report 2021-2031
Where the Enteric Soft Gel Capsules is market heading? If you are involved in this sector you must read this...Full DetailsPublished: 01 January 1970 -
Vaccines Sales Market Report 2020-2030
Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New...
Full DetailsPublished: 10 September 2020 -
Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031
Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power,...Full DetailsPublished: 31 March 2021 -
Cancer Diagnostics Market Report 2021-2031
Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel...Full DetailsPublished: 14 April 2021 -
Influenza Vaccines Market Report 2020-2030
For the companies operating in the global influenza vaccines market, there is an immense opportunity from emerging economies across the...Full DetailsPublished: 30 September 2020 -
Gene Therapy R&D and Revenue Forecasts 2020-2030
The gene therapy market is projected to grow at a CAGR of 32% in the first half of the forecast...
Full DetailsPublished: 06 March 2020 -
Vaccine Contract Manufacturing Market Forecast 2020-2030
The global vaccine contract manufacturing market was worth $2,241.6m in 2019 and is expected to grow at a CAGR of...
Full DetailsPublished: 08 April 2020 -
Global Macular Degeneration (AMD) and Other Retinal Diseases Drugs Industry and Market 2019-2029
The global macular degeneration and other retinal diseases market is estimated at $14.85bn in 2018 and is expected to grow...
Full DetailsPublished: 31 July 2019
Download sample pages
Complete the form below to download your free sample pages for Cell-Based Assays Market Report to 2030Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034
The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.
23 April 2024
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024
